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ABSTRACT
Appropriate modification of behavior in response to dynamic environmental
conditions is essential for the adaptation and survival of most biological organisims. This
adaptability allows for organisms to maximize the benefit of behavior related energy
expenditure (utility) while minimizing cost. Modern theories of locus coeruleus (LC)
function implicate a pivotal role for the noradrenergic (NA) nucleus in mediating
switches between focused behavior during periods of high utility (exploit) versus
disengagement of behavior and exploration of other, more rewarding opportunities. Two
modes of activity in LC neurons have been well characterized. During periods of accurate
and focused behavior, LC neurons exhibit supressed baseline activity and task-related
phasic bursts. However, as focus and accuracy wanes, phasic activity is supressed and
baseline (tonic) impulse activity is elevated. These experiments sought to exogenously
induce a tonic pattern of activity in LC neurons and their medial prefrontal cortical
(mPFC) efferents to test the tenets of adaptive gain theory. This theory posits that phasic
activity facilitates focused task performance whereas tonic activity promotes
disengagement from ongiong behaviors. Thus, tonic activation immediately following a
rule chage should be sufficient to improve performance on a set-shifitng task. Indeed,
DREADD mediated stimulation of LC terminals within the mPFC decreased trials to
reach criterion. However, this effect appears to result from improved application of the
new rule rather than an induction of a behaviorally flexible phenotype. Further, these
results were not seen for manipulations administered within the LC. These findings may
reflect a new understanding of the role of LC in set-shifting and flexible behavior.
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INTRODUCTION
In order for any organism to survive and thrive in a constantly changing

environment, the ability to adapt is essential. Adaptability allows an organism to
maximize benefit while minimizing cost when faced with an array of opportunities.
Inherent in this ability is the capacity to identify when utility (effectiveness of an ongoing
task in obtaining reward) is waning so that one may disengage from ongoing goals to
seek other, more rewarding opportunities.
Clinically, this ability is often measured with tests of behavioral flexibility and set
shifting, such as the Wisconsin Card Sorting Task (WCST). Such tests have revealed that
impairments in behavioral flexibility are prominent in several mental illnesses. Perhaps
the most readily identifiable example, ADHD, is characterized as an inability to
appropriately allocate attention when it is necessary (Seidman et al., 1997). An inability
to ignore ambient or predictable environmental stimuli is a key feature in schizophrenia
(Braff et al., 2001). In stark contrast, other mental illnesses such as addiction, obsessivecompulsive disorder (OCD), post-traumatic stress disorder (PTSD), and autism are
frequently characterized by inabilities to disengage attention from a particular stimulus to
attend to more pertinent concerns (American Psychiatric Association. and American
Psychiatric Association. DSM-5 Task Force., 2013).
Adaptive flexibility may rely on striking a proper balance between inattention and
focus. Frequently, inattention is characterized as a qualitatively bad trait and focus as a
good. However, the extremes of this continuum both serve a specific function in

exploring and exploiting our environment and being overly biased to either side of that
continuum could be detrimental. Understanding how this balance is maintained and
finding ways to intervene on this system when the balance has become inordinately
tipped may greatly enhance the treatments available for these disorders.

The Locus Coeruleus and Cognitive Control
Mounting evidence, including many studies from our laboratory, implicates the
locus coeruleus NE (LC-NE) system as an integral component in the ability to behave
flexibly (Usher et al., 1999; Aston-Jones et al., 2000; Aston-Jones and Cohen, 2005a, b;
Bouret and Sara, 2005; Corbetta et al., 2008). Although the prevailing theories of LC
function (adaptive gain, reorienting system, network reset) may differ in their
interpretation of how this system drives behavioral flexibility, all propose that this system
is critical for the adaptive control of behavior
(Aston-Jones and Cohen, 2005a; Bouret and
Sara, 2005; Corbetta et al., 2008).
The locus coeruleus is a relatively
small nucleus located in the dorsorostral
pons. Efferent LC projections are highly
divergent and course throughout the CNS.
Figure 1.1: Unitary action of LC
increases signal to noise ratio,
facilitating signal throughput related to
task relevant stimuli. (ServanSchreiber et al., 1990)

The LC was long thought to be the only
source of NE innervation in many
telencephalic areas, including hippocampus
2

and cerebral cortex (Berridge and Waterhouse, 2003). Although, a recent study reported
that a very small but consistent percentage (<1%) of noradrenergic axons in the mouse
somatosensory cortex derive from a different rhobomeric origin than LC (Robertson et al.,
2013). Regardless, in terms of prefrontal executive functions such as cognitive flexibility,
LC is the predominant source of adrenergic modulation of these behaviors.
Depending on the receptor subtypes present on target neurons, actions of LC
projections can impose temporally specific and opposing excitatory (α1, β receptors) or
inhibitory (α2 receptors) modulation in separate targets. This modulatory input from LC
is thought to increase the gain (synaptic responsiveness) of target cell activity, a property
that has been modeled mathematically (Fig 1.1)(Servan-Schreiber et al., 1990).
Early investigation into afferent control of the LC focused predominantly on subcortical structures describing only two major afferent projections to the LC, the nuclei
paragigantocellularis lateralis and prepositus hypoglossi (Aston-Jones et al., 1986). More
recently, it has become clear that LC also receives important inputs from frontal cortex.
Neurophysiological studies have demonstrated that microstimulation of the mPFC
exerted strong excitatory influence on LC (Jodo et al., 1998). Later, retrograde tracing
analysis from the LC demonstrated strong afferent connectivity to the LC from the
orbitofrontal cortex (OFC) and ACC in monkeys (Aston-Jones and Cohen, 2005a, b).
Due to the known roles of these cortical regions in cognitive functioning, discussed
below, they may represent highly attractive targets for future study into the afferent
cortical control of LC and subsequent influence on attentional task performance.

3

Early recording studies in LC revealed phasic activation of neurons following
salient stimuli, which provoked an orienting response (Aston-Jones et al., 1986).
However, subsequent study revealed a considerably more complex cognitive role for the
LC-NE system (Aston-Jones and Cohen, 2005a, b; Bouret and Sara, 2005; Corbetta et al.,
2008). Prior research by Aston-Jones and colleagues outlined two modes of activity in
LC neurons, termed phasic and tonic. The phasic mode is characterized as an overall
decrease in baseline firing coupled with a burst of activity following presentation of a
target stimulus but preceding a behavioral response. In contrast, tonic mode is associated
with elevated baseline LC impulse activity but little to no phasic response to stimuli or
events. During the phasic mode of LC firing, performance on various cognitive tasks that
require focused attention was facilitated in both monkeys (Usher et al., 1999; Rajkowski
et al., 2004) and rats (Bouret and Sara, 2004). This phasic firing tightly precedes, and is
thought to represent commitment to a behavioral response, rather than simply
representing sensory components of stimulus detection (Clayton et al., 2004; Aston-Jones
and Cohen, 2005a). Conversely, high levels of tonic firing without phasic activations
(i.e., tonic mode) are related to increased errors on tasks that require focused attention
(Usher et al., 1999; Rajkowski et al., 2004) as well as decreased foveation of a target
stimulus used to measure readiness and task attentiveness (Aston-Jones et al., 1996).
These patterns of LC activity are thought to represent a mechanism by which an
organism can appropriately attribute attention. Phasic mode would facilitate sustained
attention to maximize reward in a period of high opportunity (exploit). In contrast, tonic
mode would result in disengagement from a task as reward and utility wanes in order to
4

facilitate exploration of more rewarding options (explore). The AGT represents this
relationship as an inverted U-shaped curve resembling a classic Yerkes-Dodson
relationship between firing mode and task performance (Fig. 1.2)(Aston-Jones and Cohen,
2005a).
Other theories have also described a role of the LC in behavioral flexibility. One
such theory, the network reset theory, posits that, upon detection of a target stimulus,
phasic LC activity facilitates a redistribution of activity between target neural networks,
which is needed in order to execute the
cognitive shifts required for
accommodation to a dynamic
environment (Bouret and Sara, 2005).
Additionally, the reorienting system
theory interprets behavioral flexibility in
terms of an interaction between ventral
and dorsal neural networks in

Figure 1.2: Yerkes-Dodson relationship
of tonic LC activity to task performance
(Aston-Jones and Cohen, 2005a).

frontoparietal cortices. In this framework, dorsal networks form associations between
environmental stimuli and adaptive responses. Ventral networks interrupt ongoing
behavior to allow more adaptive responses to take place. This theory posits that LC
phasic input facilitates continuation of a behavior whereas high tonic input results in an
interruption of this behavior to allow a shift to take place (Corbetta et al., 2008).
Although these three prevailing theories differ somewhat in terms of their theoretical
predictions and interpretation of the current data, all three posit that LC-NA transitions
5

between phasic and tonic firing are essential to behavioral flexibility. However, to verify
this relationship it is important to demonstrate that direct manipulation of LC firing can
influence attentional control.
A Clinical Profile of Behavioral Flexibility
In the clinical setting, the Wisconsin Card Sorting Task (WCST) is a standard test
for assessing frontal lobe function, specifically as it pertains to cognitive flexibility. In
the WCST, behavioral flexibility is assessed by asking the patient to sort a deck of cards
by the stimuli shown on the cards according to a set of unknown rules that can change at
any time. The stimulus dimensions by which the cards can be sorted include suit, number,
or color, of stimuli, all of which have an array of forms. During the test, the facilitator
only indicates that sorting is correct or incorrect. When the test administrator indicates
that sorting is being done incorrectly, the patient must adopt a new sorting strategy until
the facilitator indicates they are doing so correctly.
Many patients with mental illnesses that include impairments in attention
demonstrate deficits when performing this task. Schizoaffective children (Schneider and
Asarnow, 1987) and schizophrenic adults (Choi and Kurtz, 2009) both commit frequent
preservative errors, or sorting according to old rules indicating an impairment in the
ability to drop an old strategy. Severity of opioid dependence is also predictive of and
associated with preservative errors on the WCST (Lyvers and Yakimoff, 2003; Pirastu et
al., 2006) indicating behavioral inflexibility that may result from an inability to transition
from phasic to tonic LC mode when faced with stimuli related to the drug. WCST
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impairments have also been reported in obsessive-compulsive disorder (Lacerda et al.,
2003; Shin et al., 2008) as well as autism (Kaland et al., 2008).
Of the disorders associated with impaired behavioral flexibility, ADHD may be
the most obviously related to this function. Studies assessing ADHD in children using
WCST have produced mixed results, failing to define a clear profile of cognitive
flexibility in ADHD. However, it is clear that these individuals are impaired in
performing the WCST. In a meta-analysis of child psychiatric studies using the WCST,
children with ADHD demonstrated a lower percent of trials correct, increased error
commission, completion of fewer categories, and increased perseveration (Romine et al.,
2004). Perseveration is seen in adolescents with ADHD as well (Reeve and Schandler,
2001). Thus it is noteworthy that low doses of methylphenidate (Ritalin), a drug
commonly prescribed to treat ADHD, has been found to suppress tonic LC firing while
enhancing the signal to noise ratio of the phasic inhibitory response (Devilbiss and
Berridge, 2006). These results indicate that the efficacy of methylphenidate to facilitate
task performance may rely on an overall suppression of tonic LC-NA activity that results
in decreased distractibility rather than enhanced focus.

An Experimental Profile of Behavioral Flexibility
The attention set shifting task (ASST) was designed as a laboratory analog of the
Wisconsin Card Sorting Task (Birrell and Brown, 2000). In the conventional ASST, rats
are presented with a choice of two dishes filled with two different scented digging media.
In one example, there are 2 stimulus dimensions, digging media and scent, with 2 forms
7

of each stimulus dimension presented in every trial. Only one of the two pots is baited
with a reward on any given trial; the bait corresponds to either a specific scent or a
specific digging media. The rat must learn to discriminate which one of the 4 presented
stimuli (2 media X 2 scents) predicts the food reward and dig in the corresponding pot to
receive the reward. When their performance on the task reaches criterion, manipulations
can be performed to assess behavioral flexibility. For instance, without presenting any
novel forms within the previously rewarded stimulus dimension, the rat must learn that
the opposite form within the same stimulus dimension is predictive of the food reward on
subsequent trials. This is termed reversal. If 2 novel stimuli are introduced within the
same discriminative dimension, it is termed an intradimensional set-shift. As a final
challenge, one can require the rat to learn that the previously rewarded dimension is no
longer predictive of reward but, rather, the other dimension is then relevant for receipt of
the food reward. This is termed an extradimensional shift. This paradigm quantifies
behavioral flexibility in terms of how many trials are required to learn that a different
stimulus or dimension is relevant once the rules of that task switch. This form of the
ASST has been used successfully in many experiments to test how different
manipulations can interfere with behavioral flexibility (Birrell and Brown, 2000; Tait et
al., 2007; McGaughy et al., 2008). The following studies use a simplified version of this
task, requiring lever responding according to relevant stimuli (Darrah et al., 2008;
Floresco et al., 2008; Haluk and Floresco, 2009). This type of set-shifting task lends more
temporal precision of stimulus presentation, increased throughput, and richer trial-by-trial
error analysis.
8

The Automated Strategy Set-Shifting Task (aSST)
In order to make claims as to what temporally precise manipulations are doing to
behavior, the task used to measure behavior must be also be temporally precise. The
traditional ASST presents many challenges to this end. Foremost, the stimuli used can be
quite messy and imprecise. Digging media can become scattered throughout the testing
chamber and scents may be perceptible throughout the entire testing session, rather than
only when a trial commences. Additionally, this task requires setup and cleaning between
trials, which introduces a high degree of temporal variability during the inter-trial interval.
Lastly, due to how the stimulus exemplars are presented, it is not possible to analyze the
exact type of errors the rat is making on each given trial.
The following research utilizes an automated version of this task, which overcomes many
of these challenges. This specific task, developed by Floresco and colleagues, has been
used effectively to examine the role of mPFC (Floresco et al., 2008) and ventral striatum
(Haluk and Floresco, 2009) in set-shifting behaviors. In this task, two cue lights are each
positioned above a retractable operant lever. At the beginning of the trial, one of the two
cue lights, pseudo-randomly chosen on every trial, is turned on for three seconds before
the levers are inserted into the behavioral chamber. The rat must press one of the levers
to receive a sucrose reward (see figure 3.3). Two stimulus dimensions present in the
chamber can indicate to the rat which lever will result in the reward on every trial. The rat
can either press the lever corresponding to the illuminated cue light or the rat can use a
spatial strategy, pressing only the left or right lever on every trial. Animals are initially
9

trained to press the lever under the illuminated cue light. Once they are able to do so for a
streak of 20 correct trials, they are returned to the chamber on the following day to
undergo an EDS. The first 20 trials of the EDS follow the known light rule. However,
Correct Choice
Both Levers Retract,
House Light Remains
On, 15% Sucrose
rewarded

A.

3 sec

10 sec

ITI
Chamber is dark,
levers retracted

B.
Pretraining:
Animal trained to light dimension
to at least a streak of 20 correct trials

Stimulus Presentation
One of two possible
Cue Lights and
6 or 12 KHz Tone

10 sec

Choice
House Light On,
Levers Extend

Incorrect Choice
Both Levers Retract,
House Light Off, 10s
Timeout

20,trials

Overnight
Preshift
Same light rule is
still correct

Streak,of,20
EDS
Now only rewarded
for pressing left
lever, regardless of
cue light

END

Figure 1.3 A depiction of the automated strategy set-shifting task (A). Rats are pretrained to follow the light cue (or tone on ChR2 experiments only) to receive a
sucrose reward. Once able to execute this rule correctly for a streak of 20 trials the
rats will be returned to the testing chamber to perform the EDS (B).
without cueing the rat in any way, the rule switches so that the rat must press according to
the spatial position of the lever, regardless of the position of the cue light. The rat must
learn that the old rule is no longer discriminative of the reward, disengage from that
strategy, and learn to follow the new rule. According to AGT, tonic stimulation of LC
10

immediately following the rule change should facilitate disengagement from the old
strategy evident by a decrease in perseverative behavior. If the rat ceases perseveration
sooner, it should take the rat fewer trials to reach criterion performance on the new rule.

A Simple Neural Circuit for Behavioral Flexibility
As previously mentioned, LC receives considerable afferent drive from the frontal
cortex (Jodo et al., 1998). Retrograde tracer analysis has determined that ACC projects
to LC (Aston-Jones and Cohen, 2005a, b). When engagement in an ongoing task
becomes ineffective for attaining a reward, it would be adaptive for the LC to transition
from phasic to tonic firing to facilitate task disengagement and exploration for other
possibly rewarding opportunities. Due to its widely theorized role as a monitor of
conflict in task performance, it is likely ACC may be driving this transition. This theory
has been largely derived from electrophysiological and imaging studies in humans. These
data have shown that the ACC responds to a broad spectrum of negative stimuli related to
monetary loss (Williams et al., 2004), social rejection (Eisenberger et al., 2003), and error
commission (Brázdil et al., 2002; Fitzgerald et al., 2005; Yeung and Cohen, 2006).
Additionally, task difficulty (Barch et al., 1997) and tasks imposing conflicting choices
such as overriding a prepotent response (Barch et al., 2001), or choosing between two
overlapping choices (Barch et al., 2000), have been shown to modulate activity in the
ACC. However, it remains to be determined how this role of the ACC is functionally
incorporated into more complex behaviors. There is ongoing controversy as to exactly
what information is being encoded by the ACC. Some reports indicate that ACC in
11

primates does not respond simply to conflict inducing stimuli (Nakamura et al., 2005;
Emeric et al., 2008), but is modulated by error commission, reinforcement, and conflict
related to opposing responses (Ito et al., 2003). It has also been demonstrated that
activity in rat ACC increases during periods of attention preceding stimulus presentation
as well as immediately following an incorrect trial. This may indicate that the ACC is
determining probability of error commission for possible behaviors by comparing against
the success of prior strategies. Within the context of the this study, we hypothesize that
ACC monitors conflict in ongoing performance, and that, when probability for conflict
outweighs the cost of performing the task, the ACC helps to drive the transition from
phasic to tonic firing. This would, in turn, facilitate task disengagement and increased
behavioral flexibility.
The role of LC input to the cortex in behavioral flexibility has been more clearly
delineated. In rodents, lesions of the mPFC and its subfields were shown to impair
behavioral flexibility on strategy-based tasks such as various radial arm mazes (Joel et al.,
1997) or place-response cross maze tasks (Ragozzino et al., 1999). Additionally, mPFC
ibotenic acid lesions selectively impaired extradimensional shifting on the ASST (Birrell
and Brown, 2000). Additional data suggest that it is the LC-NA inputs into these regions
that modulate flexibility in this task. 6-OHDA lesions of the dorsal noradrenergic bundle
(DNAB) of ascending NE fibers from LC (the input of NE to mPFC) were found to also
selectively impair extradimensional shifting. Similar results were found for selective
noradrenergic de-afferentation, of the mPFC (McGaughy et al., 2008). Together, these
results consistently reveal that LC-NA innervation of mPFC is necessary for behavioral
12

flexibility measured by the ASST. However, sufficiency of LC-NA input into the mPFC
for mediating behavioral flexibility has yet to be demonstrated due to methodological
challenges that have only recently been overcome.

Emerging Tools for Cell Specific Neural Control
Until recently, methods for activating or inhibiting neurons have been unable to
unify cell-type specificity with precise temporal control. Pharmacological methods,
although somewhat specific, are unable to reproduce the rich, temporally precise, and
dynamic neural signals conveyed by neural units. On the other hand, electrical methods
can endow temporally precise control of neural units, but lack specificity as nearby units
of all types are affected. Newly developed tools using microbial opsins provide a means
to achieve both criteria. Type I opsins are a class of light sensitive proteins that have been
isolated from algae and fungi. These proteins bind the photopigment retinal in all-trans
conformation, which photoisomerizes to the 13-cis conformation while remaining bound
to the opsin protein. This conformational change in the photopigment induces a
conformation change in the opsin that will produce changes in local ion-flux. Depending
on the nature of the opsin, the resulting ion flux can be either excitatory or inhibitory and
can be triggered by specific wavelengths of light. These proteins can be delivered to cells
by viral vectors with cell-type specific promoters and stimulated by small, implantable
optical fibers connected to a laser of appropriate wavelength (Boyden et al., 2005; Fenno
et al., 2011).
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Using these techniques, researchers have demonstrated unprecedented precision
and control, both excitatory and inhibitory, of brain neurons (Boyden et al., 2005; Stuber,
2010; Stuber et al., 2010; Tye et al., 2011). Results preceding this study have achieved
this degree of control in rat LC-NE neurons in-vivo using the excitatory cation channel
opsin channelrhodopsin-2 (ChR2) under control of a artificial dopamine β-hydroxylase
(DBH) promoter PRSx8 (Vazey et al., 2011a; Vazey et al., 2011b). These types of
manipulations are sufficient to drive modulations in target tissues (Boyden et al., 2005;
Kanbar et al., 2010; Stuber, 2010; Stuber et al., 2010; Tye et al., 2011) and have
produced measurable changes in behaviors of rats (see below) and mice such as sleep to
wake transitions and behavioral arrest (Carter et al., 2010) and bi-directional control of
anxiety (Tye et al., 2011). Although expression of these proteins can be more easily
accomplished by transgenic manipulations in mice, the limited behavioral range of these
animals impairs study of complex cognitive behaviors.
Another emerging tool, pharmacosynthetic DREADDs, also confer unprecedented
cell specificity of stimulation or inhibition while also preserving typical receptor kinetics
of neural systems. DREADDs are muscarinic g-protein coupled receptors that activate
endogenous Gs, Gi, or Gq cell signaling pathways. However, through a process of
controlled selection, these particular variants have evolved in a directed manner so that
they bind no endogenous ligand. Instead, these receptors bind and are activated by the
biologically inert designer drug CNO. When bound, these receptors activate their
corresponding g-protein pathway. Studies have shown DREADDs to be sufficient for
activating (Alexander et al., 2009; Krashes et al., 2011) and inhibiting (Armbruster et al.,
14

2007; Nair et al., 2013) target cells. Experiments using DREADDs have shown them to
be sufficient to modulate depression like behaviors (Nair et al., 2013), reward learning
(Ferguson and Neumaier, 2012), feeding (Krashes et al., 2011), locomotion, and seizure
activity (Alexander et al., 2009).
The following studies seek to employ these novel tools for specific neural control
in the LC of rats performing the aSST. These new optogenetic and pharmacosynthetic
techniques could extend these results and directly answer theoretical questions posed by
AGT. In doing so, these experiments reveal that cell specific stimulation of LC efferents
in PFC is sufficient to improve set-shifting performance, whereas stimulation within LC,
either by optogenetic or DREADD based means, failed to improve set-shifting
performance. Further, improved performance on the task does not appear to result from a
reduction of perseverative behavior but, rather, a reduction in regressive responding. That
is, the animals receiving this stimulation are better able to consistently utilize a new
strategy once it has been discriminated.

15

2.

TOWARDS A FRAMEWORK FOR OPTIMIZED SET-SHIFTING
According to adaptive gain theory, induction of a tonic pattern of activity in LC

cells should result in a flexible behavioral phenotype that will allow for exploration of
environmental contingencies and modification of ongoing behavior. Oppositely,
induction of phasic activity should result in a focused behavioral phenotype, fortifying
ongoing behavior. Thus, the delivered stimuli could have either beneficial or detrimental
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Figure 2.1 Varying patterned activity of LC during different epochs of a set-shifting
procedure could produce differing behavioral phenotypes that could either be
advantageous or detrimental to overall task performance.

effects on shifting behavior depending on the timing and pattern of the stimulation
delivered (see figure 2.1). Optimal performance would initially require focused
performance on the known rule before the shift. However, following the rule change, LC
would optimally switch into a pattern of elevated tonic activity to facilitate exploration of
new task contengencies. Then, as the animal began to acquire the new rule, LC would
transition back into a phasic pattern to facilitate consistient expression of the newly
learned behavior.
In theory, temporally inverting these patterns should lead to the worst behavioral
outcome on a set-shifting task. Tonic activity during the pre-shift epoch could impair
consistient execution of the known rule. Phasic activity immediately following the rule
change would prevent the animal from disengaging from the behavior that is no longer
beneficial. Finally, as the animal began to discriminate the new rule, sustained tonic
activity might prevent its consistient application on every trial.
Accounting for the assumptions of adaptive gain theory, it is clear that the
stimulation delivered to LC throughout these procedures would need to be as temporally
precise as possible both in terms of duration and timing. These sets of experiments aimed
to induce a pattern of tonic activation immediately following the rule change to induce a
flexible behavioral phenotype during the acquisition phase of the new rule. The
behavioral outcome of this manipulation should manifest as a decrease in perseverative
behavior, which should allow the rat to discriminate the new rule sooner. This would
result in an overall decrease in the trails taken to reach criterion. This chapter will outline
a number of preliminary experiments undertaken, which served to optimize the method of
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stimulation and behavioral parameters to selectively stimulate LC and its PFC efferents
within the aSST.

Verification of Optogenetic LC Stimulation
Before attempts to employ optogenetic methods within a complex behavioral
paradigm, intitial efforts focused on developing and verifying techniques to administer
these manipulations in the awake, behaving rat. First, the small size of LC and its location
directly adjacent to the 4th ventricle required determination of surgical methods for
consistiently accurate viral injection and implantation. Second, the viral construct used to
transduce ChR2 in LC required vetting for specificity and potency. Finally, sufficiency of
these methods to produce quantifiable behavioral and physiological changes that are
consistient with an LC elicited increase in arousal needed to be demonstrated.
Methods: animal care and surgery. All methods used were in compliance with the
National Institutes of Health Guide for the Care and Use of Laboratory Animals and
were approved by the Medical University of South Carolina Institutional Animal Care
and Use Committee. Animals were all housed in a temperature and humidity-controlled
room under a reverse 12 h light/dark cycle (lights on at 6pm) with food and water
available ad libitum. Animals were allowed 5 days for acclimatization and handling
before any experimental procedures commenced.
The lentiviral vector used in this initial trial study was cloned and packaged by the
University of Pennsylvania Viral Vector Core. LC specific expression of the mCherry
reporter tagged ChR2 was achieved using the synthetic dopamine beta-hydroxylase
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promoter PRSx8 (Hwang et al., 2001). For surgical procedures, rats were anesthetized
and maintained at a therapeudic plane of anesthesia with isoflurane. They were then
placed into a stereotaxic frame and their nose was tiled downward so that bregma
measured 2 mm below true lambda. This was done so that LC targeted implements would
avoid the transverse sinus. A craniotomy was then drilled at AP -3.7 mm, ML ± 1.2 mm
as measured from true lambda. Bone fragments and dura mater was cleared from the
surface of the cerebellum to ensure clear entry of glass pipettes into tissue. A chloridated
silver wire was inserted into a pontamine blue solution filling a glass pipette with a tip
precisely broken at broken at 2.5 µm to produce a high impedance recording electrode
(~20MΩ). This electrode was attaced to a hydraulic micromanipulator (Stoelting) and
lowered ventrally at AP -3.7 mm, ML ±1.2 mm. Recordings were made as the pipette
was lowered in this vicinity until single LC units could be discriminated based on their
waveform components, slow basal rate (2-3 Hz), and burst pause activity resulting from a
brief toe pinch (Aston-Jones and Bloom, 1981). When LC had been identified, a double
barrel pipette consisting of an identically pulled recording pipette precisely glued 200 µm
below the tip of an angled injector pipette with a 40 µm opening was filled with 3 µl of
the viral construct and attached to the micromanipulator. This double pipette was then
lowered through the same track until LC cells were again located. The virus was
unilaterally delivered with brief pheumatic pulses (Picospritzer III, Parker Instruments)
over a 100 µm ventral to dorsal extent within the identified LC area. The injector then
remained in place for 15 minutes to allow for diffusion of the virus before it was
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withdrawn. A 22G guide canula (Plastics One) was then lowered 1.5 mm above the
dorsal most identified LC cell and secured in place with dental cement.
Four skull screws with tightly wound 0.010 inch diameter stripped stainless steel
wire were affixed to the skull for recording of cortical (CxEEG) and hippocampal
(HpEEG) electroencephalographic activity. Each wire end was soldered to a female
Amphenol pin. CxEEG leads were placed at AP -1.0 mm, ML ±3.0 mm (positive,
measured from bregma) and AP +1.0 mm, ML ±4.0 mm (negative, measured from
lambda). HpEEG leads were placed at AP +4.0 mm, ML ±1.0 mm (positive, mesured
from lambda) and AP +3.0 mm, ML ±1.0 (negative, measured from bregma). In addition,
two partially stripped wires were threaded under each of the animals’ trapezius muscles
to record electromyographic (EMG) activity of the head and neck. The female amphenol
leads were then plugged into a six-pin plastic coupler (Plastics One) and the entire
apparatus was secured to the skull with dental acrylic. Rats were then returned to their
homecage and allowed two weeks for recovery and viral expression.
Methods: optogenetic LC stimulation and EEG recording. Experiments were
performed a minimum of one hour into the animals’ light cycle. Rats were acclimated
over the course of one week to fall asleep in their homecage placed inside a soundproofed
chamber. On stimulation and recording sessions, rats were lightly anesthetized to allow
for insertion of the optical fiber and attachment to the EEG recording plug. A 200 µM
diameter optical fiber (Thorlabs) was glued inside a 28 gauge injector canula (Plastics
One) and precision cut with a diamond knife to protrude 0.5 mm from the end of the
injector, which protruded 1 mm from the guide canula when inserted and secured. A six20

channel cable fitting the coupler (Plastics One) was plugged in and secured. The optical
fiber was then attached to a 473λ solid-state laser (OEM Laser Systems) and the EEG
cable through a bioamplifier (CWE Inc.) to a data acquisition interface (CED Micro
1401). The CED was also used to deliver TTL pulses to drive the laser and to process
EEG recordings. Spike 2 software (CED) was used to acquire EEG/EMG traces in real
time and to simultaneously deliver trains of stimulation with the laser.
The rat was allowed to wake from anesthesia and was then placed into the
soundproofed chamber to sleep. Stimulation was delivered during non-REM sleep as
verified by the presence of slow-wave CxEEG activity and lack of EMG activity. Five
minutes of continuous of slow-wave activity was recorded before stimulation was
delivered. The laser was calibrated to deliver 15 ms pulses of light at intensities of 2.5, 5,
7.5, and 10 mW and frequencies of 1.5, 3, 5, 10, and 15 Hz. Each frequency was
delivered for a single intensity before laser output was increased. Each train of
stimulation was delivered for 20 seconds or until the animal woke from sleep. If the
stimulus train was insufficient to wake the animal, the next highest frequency was
delivered following a one-minute wait. If EEG showed a change in slow wave activity of
if the animal woke, another 5-minute baseline of SWS was taken before the next
stimulation was delivered. If the animal woke, the same stimulus train was delivered. If
the animals’ SWS was disrupted, but the animal did not show a behavioral waking
response the next highest stimulus train was delivered.
Methods: verification of viral expression and implant accuracy. Animals were
deeply anesthetized with an overdose of Ketamine/Xylazine and perfused through the
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heart for 30 seconds with saline and then 5 minutes with cold 4% paraformaldehyde for
tissue fixation. The brain was then removed and placed in 4% paraformaldehyde
overnight for post-fixation and transferred the following day into 20% sucrose for
cryoprotection and kept in this solution until buoyancy was lost. Before slicing, the brain
was frozen on dry ice and mounted on a Leica cryostat for sectioning. Four sets of 40 µm
sections were taken through LC and stored in phosphate buffered saline (PBS) with 0.1%
sodium azide until staining. One set of LC sections was washed 3x5 minutes with PBS
and then 3x5 minutes in phosphate buffered saline with 0.3% Triton X-1000 (PBST).
Sections were then incubated in 3% normal donkey serum (NDS, Jackson
ImmunoResearch) for 60 minutes. Sections were simultaneously incubated overnight in
mouse anti-TH (1:1000, Immunostar 22941) and rabbit anti-DS Red (1:500, Clontech
632496) in PBST and 3% NDS. The following day, the tissue was washed 3x5 minutes in
PBST and then transferred into flourophore-conjugated secondary antibodies for 3 hours.
Donkey anti-mouse Alexa Fluor 488 (1:500, Invitrogen) was used to visualize TH
positive LC neurons; and donkey anti-rabbit Alexa Fluor 594 (1:500, Invitrogen) to
visualize mCherry tagged ChR2 expression. Slices were washed 3x5 minutes in PBS,
mounted, and coverslipped with Citiflour mounting medium. Sections were imaged and
captured using a confocal laser-scanning microscope (Leica TCS SP5) with argon,
argon/krypton, and helium/neon lasers. Damage resulting from the guide and injection
canulae was tracked throughout the tissue. Since injection of dyes such as pontamine blue
would disrupt visualization of florescent labeling, the most ventral point of tissue damage
along the canulae tracks was found and compared to the Paxinos and Watson rat brain
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atlas (Paxinos and Watson, 2008) to localize position of injection canulae carrying the
optical fiber.
Results. Animals injected with the PRSx8 lentiviral vector under these surgical
parameters demonstrated sufficient expression of mCherry tagged ChR2. Expression of
ChR2 was highly selective for TH-positive LC cells. Further, canula implants were
effectively targeted at LC (Figure 2.2).
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E

Figure 2.2 TH-positive LC cells (A) express mCherry fused ChR2 (B) selectively
within the LC (images merged in C). Canulae tracks (D) accurately target LC (E, black
arrow).

In a ChR2 expressing animal with cannulae accurately placed immediately dorsal
to LC, a 3 Hz train of 15 ms, 5 mW light pulses was sufficient to reduce slow-wave
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activity during non-REM sleep (example shown in Figure 2.3). Immediately prior to the
delivery of stimulation, CxEEG displayed slow-wave activity associated to non-REM
sleep. Shortly after initiating the train of stimulation, low frequency CxEEG activity was
eliminated, consisitent with a predicted increase in arousal. This was consistiently
followed closely by a waking resonse. A power analysis of the trace shown in Figure
2.3A reveals a dramatic decrease in power at low frequencies during the stimulation
period compared to the preceeding epoch of SWS.
A

B

Figure 2.3 An example of ChR2 mediated LC stimulation producing a decrease in
SWS associated low-frequency CxEEG activity consistent with an increase in
arousal. A raw CxEEG trace (A) is shown before, during, and after stimulation
was delivered. A power analysis (B) for the boxed regions in A is reveals a sharp
decrease in power for all frequencies below 18 Hz.

Discussion. The results of this set of pilot experiments provide proof-of-concept
for ChR2 mediated stimulation of locus coerulus in an awake, behaving animal.
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Consistient, LC specific expression of ChR2 was achieved through electrophysiologically
targeted injections of the lentiviral vector under control of the PRSx8 promoter. Further,
delivery of light pulses was able to elicit a quantifiable increase in arousal and a
behavioral waking response. One limitation to this approach was the fact that the animal
needed to be anesthetized in order for the optical fiber to be inserted without breakage.
For cognitive behavioral testing, anesthesia immediately preceeding an EDS could
potentially interfere with the animals’ ability to perform the required behavior. To adress
this issue, subsequent experiments incorporated durable, chronically implantable optical
fibers that could be easily attached to fiber optic cables without the need to sedate the
animal.

Optogenetic Stimulation of LC and Optimization of Set-Shifting Procedures
Initial attempts were made early on in the development of these procedures to
further the capabilities of the task put forth by Floresco, et al. (Floresco et al., 2008).
Using the more tradtional digging set-shift task, it was clear that noradrenergic
manipulations produced deficits that were specific to extradimensional shifts (Tait et al.,
2007; McGaughy et al., 2008). In this task, it is possible to perform intradimensional
shifts (IDS) in which new forms of stimuli within the same discriminatory dimension are
introduced, requiring the rat to learn a new discriminator while staying within the same
dimension. This type of shift shows that the rat can form specific attentional sets.
Additionally, this task allowed for reversals following every shift type. In a reversal, none
of the stimuli are changed, but the previously ignored stimulus within the relevant
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dimension becomes the discriminator. Reversals are possible within the operant based
task, but until now had only been performed within the spatial lever dimension. These
tasks, however, do not allow for parsing of different error types. Incorporation of new
forms of stimuli that could allow for IDS or cue-based REV could strenghten potiental
finding by allowing closer comparision to the published literature.
To this end, early optogenetic set-shifting experiments sought, largely without
success, to incorporate new types of stimuli and behavioral strategies that could allow for
IDS and multi-dimensional reversals. Some of those approaches are briefly summarized
here. Strobing lights were introduced within the light dimension. Instead of only one light
being presented to the rat, one of the lights remained on constantly while the other
strobed. Here the rat could choose to press the solid or the strobing light. However, this
stimulus required a considerable deal of extra training and rats varied greatly in their
tolerance to perform this discrimination. Many rats would simply omit trials. Also within
the light dimension, we attempted to assess whether a rat could learn to press the lever
opposite the illuminated cue light. Rats were considerably better at performing
discriminations for the lit cue light, so this difference in stimulus salience did not make it
a good candidate for set-shifts. Colored lights were also considered. However, rats have
extremely limited color vision and even that is restricted to the green to ultraviolet
wavelengths, with maximum sensitivity to blue (Jacobs et al., 2001). It was concluded
that modifications of the light dimension may prove too difficult to employ.
Another option was the addition of auditory stimuli. One way this was attempted
was to maintain a spatial approach similar to the cue light. In this arrangement, one
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speaker was positioned above each cue light. However, only one speaker played a tone on
a given trial. This discrimination too also proved too difficult for the rat to incorporate
into this task. This may be due in part to the animal being able to move about freely when
the tone was presented, as their position within the behavioral chamber could change
their perception of the source of the tone. Textured tones that either rose or fell, broken
vs. solid tones, and clicks were also tried with varying, but inconsistient success.
One approach that did achieve a measure of success was presentation of a single
tone. This single tone was either a high or low frenquency. Rats were required to press a
lever that corresponded to either the high or low tone. By presenting either a 6 or 12 KHz
tone simultaneously with the cue light, rats most rats were eventually able to execute a
streak of 20 correct trials performing a tone discrimination. However, it was rare that a
rat was able to execute a shift to this discrimination within a single session. Nonetheless,
it did provide an additional stimulus domain to which the rat could be initially trained and
shifted from.
The following experiments incorporated this tone training into the operant setshift task. Rats performed EDSs and reversals while optogenetic stimulation was
delivered to LC. It was hypothesized that a continuous 3 Hz train of 15 ms light pulses
delivered for 15 trials immediately following the rule change would induce a behavoirally
flexible phenotype that would decrease perseverative behavior and allow the animals to
learn the new rule sooner. Indeed, unilateral stimulation of LC was able to produce a
decrease in perseverative responding when than animal was shifted from the light or tone
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dimension. However, this effect was transient, at best, and did not result in a significant
overall improvement in the rats performance of the EDS.
Methods: behavioral pretraining. Rats were allowed one week for acclimation
and and handling before starting experimental procedures. During training, rats were fed
a maximum 5 chow pellets daily and were restricted to no greater than 20% less than
their free-feeding weight. All operant training took place in a MedAssocitates chamber
placed inside a sound attenuating box. The behavioral apparatus consisted of a centrally
positioned fluid reward well flanked on either side by a retractable lever and cue light and
above by a house light. The fluid reward well was connected to a 20 ml syringe in a
syringe pump (MedAssociates) that would deliver 0.05 ml of 15% sucrose on a rewarded
trial.
All rats began on FR1 training. During an FR1 session, the house light would
remain illuminated and one of the two levers would be inserted into the box for the entire
session. Any press of the lever that did not take place when the reward pump was already
activated would result in delivery of the reward. Rats underwent one 30 minute session
for each lever daily until they were able to attain 50 rewards on each lever on a single
day. Once this phase of training was completed, rats were required to press a presented
lever within 10 seconds. In this phase, a trial would begin with the house light off and
both levers retracted. The house light would turn on and one of the two levers would be
extended into the chamber. The rat was required to press the lever within 10 seconds to
receive the reward. Each lever was presented 45 times during a session and the rat was
required to omit no more than 5 trials in a given session after a minimum of 4 total
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sessions before proceeding to the next phase of training. On the last day of this phase,
the rats’ side bias was assessed. Here, at the beginning of a trial both levers were inserted
into the chamber. Pressing either of the levers (free choice) resulted in delivery of the
reward. The next trial was a forced choice requiring the rat to choose the opposite lever
from the free choice. This was repeated until the rat made the correct forced choice and
reset the next trial to a free-choice. This continued until the rat had carried out 9 free
choice sessions and the lever most often pressed during the free-choice was determined to
be the rats’ side bias.
The final phase of pretraining for these experiments required the rat to disciminate
a tone stimulus amid distractor stimuli. Again, before a trial, all lights were extinguished
and levers retracted. The trial began with a pseudorandom simultaneous presentation of
either a 6 or 12 KHz pure tone and illumination of one of the two cue lights. These
stimuli were presented for three seconds before both levers were inserted into the
chamber. If the 6 KHz tone was played, the rat was required to press the left lever, or the
right lever for the 12 KHz tone. The cue light was not predictive of the rewarded lever.
Rats carried out 300 trials daily, 6 days a week, until they were able to execute a streak of
20 correct trials in a given session.
Methods: injection of viral vectors and implatation of optical fibers. With a few
notable departures, the surgical procedures used herein follow closely with those
described in the previous section. EEG and EMG leads were not required for these
procedures, so two skull screws were affixed to each of the parietal bones to anchor the
implant to the skull. Initially, LC virus injection and optic implantation was performed
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unilaterally as before. Later experiments attempted to transduce virus and implant optics
bilaterally. In these procedures, LC was electrophysiologically located and injected as
before. The injector was then raised out of the brain and cleared by puffing air through
the injector into a small volume of saline. The injector was then refilled with another 1.5
µl aliquot of the lentiviral vector which, which was injected at the same depth and ML
±2.5 from the localized LC. Also new to these procedures was the incorporation of a
control viral vector. As with the ChR2 vector, translation of the viral product was
controlled by the PRSx8 promotor that is specific to Phox-2B expressing cells like the
LC. However, transduction with this virus only produced the reporter protien mCherry
and not ChR2. Methods for histological verification of viral transduction follows from
the previous section.
These experiments also incorporated chronically inplanted fiber optics that did not
require sedation of the animal to connect the light source. Unilateral implants consisted of
a precisely polished 200 µm optic core epoxyed inside a 2.5 mm stainless steel lucent
connector ferrule (Precision Fiber Products). Bilateral implants used the same core, but
were made using individual 1.25 mm ceramic or stainless steel ferrules precisely secured
to a common base so that the ferrules measured 2.4 mm center-to-center. Just before
implantation, the end of the optic fiber was cut with a diamond knife and the implant was
connected to the laser. For each implant the settings for the laser resulting in 5 mW
output was recorded for calibration during stimulated test sessions. These implants were
then attached to a stereotaxic holder and lowered the same LC coordinates just above the
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most dorsally located LC cell. Following surgery, animals were allowed 2 weeks for
recovery and viral transduction before resuming behavioral testing.
Methods: operant set-shifting procedures. Following the two week recoevery,
animals were returned to the behavioral apparatus and underwent a retraining session on
the tone stimulus before EDS testing began. During this retraining session and throughout
EDS testing, the rats’ implant was connected, via a ceramic split sleeve, to a custom
FC/PC patch cable terminating with a lucent connector of the same size as the implant.
Once the animal was able to adequately recall the tone discrimination they could begin
performing EDSs and REVs. The first EDS the rat performed proceeded from the tone
dimension. The initial 20 trials of the first EDS were performed identically as in the
initial tone discrimination. On the 21st trial the relevant stimulus dimension was switched
without any additional cueing to the animal other than the loss of reward for performance
of the incorrect behavior and a 10s timeout. On the first EDS the animal had to switch
from the known tone discrimination to adopt a spatial strategy whereby they were to
press only the lever opposite their side bias on a given trial. On EDS sessions where the
animal received optogenetic stimulation, 5mW, 15 ms light pulses were continuously
delivered at 3 Hz throughout the first 15 trials following the rule change. Following the
rule change, rats continued performing trials until they could execute a streak of 20
correct on the new rule or until they had recieved 520 total trial presentations.
Next rats performed a reversal within the spatial dimension. Stimulus presentation
throughout all trials remained consistient regardless of which type of shift was
performed. As with EDS, the first 20 trials required the rat to press the lever opposite
31

their side bias, the same rule they had previously learned in the first EDS. However, on
the 21st trial, the rat was then required to press the opposite lever to receive the reward.
The progession through subsequent shifts is shown in figure 2.4. To counterbalance for
order effects, rats received optogenetic stimulation either on the first 3 or final 3 shifts
performed.
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Figure 2.4 The progression of optogenetic set-shifting procedures. The progression
through each rule is shown on the top row. A change between rules is denoted by the
proper shift-type in the second row. Animals were tonically stimulated either on the first or
final 3 shifts to counterbalance order effects.

Methods: dependant variables and statistical analysis. This operant procedure
produces a rich set of dependant variables that can provide a great deal of insight into the
animals progress throughout the set shift. Pre-shift percent correct is calculated for choice
trials during the 20 trial epoch preceeding the rule change. If the animal failed to reach at
least 65% correct during the pre-shift period, that shift was not used in the analysis. Total
correct and incorrect trials during the post-rule change epoch until the point the animals
reaches a streak of 20 correct trials are added to calculate trials to reach criterion (TTC).
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Incorrect trials can be split into 3 error types. Perseverative and regressive errors both
denote the same error behavior, an incorrect choice that follows the old rule. The
difference in these two types of errors are the frequency and the point at which they occur
during the set-shift session. To calculate, trials are divided into bins of 8 in which it was
possible to make this sort of error. After the first bin following the rule change, the first
bin in which the animal commits fewer than 6 of 8 errors of this type is the last bin that
perseverative errors are counted. The remaining errors of this type are all termed
regressive errors. This differentiation is thought to reflect persistience on an unrewarding
behavior (perseveration) versus a failure to consistiently maintain a rewarding behavior
(regressive). On reversals, bins of 16 with a cutoff of 12 are used since the animal can
make a perseverative response on every trial. On a small number of EDS trials, animals
may make a choice that would not have been correct under the old rule or the new rule.
These errors are termed non-perseverative errors.
These behavioral data include within-subject comparisons for animals over
multiple EDSs and reversals as well as between-subjects comparisons for animals who
receive different viral injections. Further, analysis of binned perseverative errors may
have different numbers of observations depending on when the animal met criteria. As
such, data in these experiments were analyzed using linear mixed models. A diagonal
repeated covariance structure was used as large differences in variance over multiple
observations was not a likely concern.
Results: unilateral optogenetic stimulation during the EDS. A total of 15 animals
with accurate implant placement and unilateral virus expression in LC were used for this
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study. Of those 15, 11 animals were transduced with ChR2, and 4 with the mCherry
control virus. A total of 31 EDS observations were made from ChR2 animals, 22 from
unstimulated EDS and 19 from stimulated EDS. 16 total observations were made for
control animals, 8 from stimulated EDS, 8 unstimulated EDS. On reversals, 5
observations were made for control animals (2 unstimulated, 3 stimulated) and 17 for
ChR2 animals (8 unstimulated, 9 stimulated).
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Figure 2.5 Overall performance on EDS is unaffected by ChR2 mediated stimulation of
LC. Within subjects comparisons are represented by clustered bars. Unstimulated trials
are shown in red and stimulated in blue. Percent accuracy on the 20 pre-shift trials is
shown in A, TTC in B, and omissions in C.
Considering all shifts together, there were no baseline differences in the animals’
ability to recall the relevant rule as pre-shift accuracy did not differ for any group (FLMM(1,
38.143)=0.131,

p=0.720, figure 2.5A). Likewise, LC stimulation produced no change in the

animals’ overall TTC (FLMM(1, 34.090)=1.866, p=0.181, figure 2.5B). There were, however,
significant differences in the number of omissions (FLMM(1,41.063)=4.330, p=0.044, figure
2.5C). This difference was found only in control animals and resulted from a decrease in
omissions on unstimulated trials.
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Error analysis reveals no significant interactions of virus*stimulation for any error
type. There was no significant difference in the comission of perseverative errors (FLMM(1,
18.928)=1.348,

p=0.260, figure 2.6A), regressive errors (FLMM(1, 23.684)=0.733, p=0.400,

figure 2.6B), or non-perseverative errors (FLMM(1, 33.380)=0.001, p=0.981, figure 2.6C).
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Figure 2.6 Analysis of error types show no significant effects as a result of ChR2
mediated stimulation of LC. Clustered bars represent within subjects comparisons.
Unstimulated EDSs are shown in red, stimulated in blue. Perseverative errors are shown
in A, regressive in B, and non-perseverative in C.

A closer analysis of timcourse of perseverative error comission is shown in
figures 2.7 and 2.8. The first 6 bins used in the calculation of perseverative and
regressive errors are plotted. It was hypothesized that optogenetic stimulation of LC will
decrease perseverative errors. However, when not accounting for the type of shift the
animal was performing (virus*stimulation*bin), no effect of optogenetic stimulation was
seen (FLMM(5, 73.235)=0.769, p=0.287, figure 2.7). However, there were different types of
shift the animal could have executed. When we compare shifts from an unpredictable
dimension (light or tone) to shifts from the predictable spatial that does not require a trialby-trial cue presentation, we find a main effect of shift type (FLMM(1, 219.049)=69.163,
35

p<0.001) and a significant four-way interation of virus*stimulation*shift type*bin
(FLMM(5, 73.235)=1.935, p=0.049).
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Figure 2.7 A time course analysis of perseverative behavior irrespective of the type of
shift the animal performed. The dotted line represents the cut-off used to determine
when perseverative behavior has ceased. Unstimulated (green) and stimulated (orange)
shifts by mCherry animals are shown with unstimulated (red) and stimulated (blue)
EDSs by ChR2 animals.
To attempt to parse the four-way interaction, each shift type was considered
separately. On an EDS from the spatial dimension, the previous rule did not require the
rat to wait and receive a cue to perform the correct behavior. On these types of shifts,
tonic stimulation in ChR2 animals appears to have no effect on perseverative behavior
(figure 2.8A). However, on EDSs from an unpredictable dimension, the rat had to
withhold responding to receive either a light or tone cue that dictated which lever was to
be pressed. On these types of shifts, it appears that ChR2 rats perseverate less when
receiving stimulation compared to unstimulated EDS and stimulated mCherry controls.
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Indeed, statistical comparison of bin 1 for ChR2 animals on unpredictable shifts shows
that this difference is significant (t=11.184, p=0.018).
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Figure 2.8 Shifts from a predictable spatial rule (A) are compared separately for
shifts from an unpredictable rule (B). ChR2 animals appear to make fewer
perseverative responses on stimulated shifts (blue) from an unpredictable
dimension compared to unstimulated EDSs (red) and unstimulated mCherry
controls (green). The dashed line represents the criteria level for classification of
perseverative errors.
Results: unilateral optogenetic stimulation during reversals. As with EDS,
optogenetic stimulation during reversals also failed to produce significant changes in
measures of overall task performance. Groups did not differ on baseline performance
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before the rule change (FLMM(1, 16.370)=0.508, p=0.486, figure 2.9A). Following the rule
change, there were no significant differences in TTC (FLMM(1, 17.659)=0.036, p=0.851,
figure 2.9B) or omissions (FLMM(1, 16.871)=1.375, p=0.257, figure 2.9C). Analysis of error
commission also reveals no differences in perseverative (FLMM(1, 16.647)=3.811, p=0.068,
figure 2.9D) or regressive errors (FLMM(1, 15.414)=1.653, p=0.217, figure 2.9E). Timecourse analysis of perseverative behavior, as was done for EDS, does not reveal any
significant differences due to LC stimulation (FLMM(1,12.265)=1.361, p=0.268, figure 2.10).
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Figure 2.9 Analysis of reversal performance reveals no effects due to optogenetic
stimulation. Within subjects comparisons are represented by clustered bars. Unstimulated
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Figure 2.10 Binned analysis of perseverative behavior on reversals reveals no changes
resulting from optogenetic stimulation of LC. The dashed line represents the cutoff for
errors to be counted perseverative. Groups shown include stimulated (orange) and
unstimulated (green) REV in control animals and stimulated (blue) and unstimulated
(red) REVs in ChR2 animals.
Results: bilateral optogenetic stimulation in EDS. Failing to observe any changes
in overall task performance as a result of optogenetic stimulation of LC, a pilot
experiment attempted to bilaterally stimulate LC in hopes that exerting tonic activity in
both nuclei might produce the hypothesized effects. Of the animals with bilateral virus
expression and accurate bilateral fiber optic implantation in LC, 4 animals were
transduced with ChR2 and 3 with mCherry. A total of 10 EDS observations were
included for each group. Again, bilateral ChR2 stimulation failed to produce any
differences in the overall performance on any of the EDS variables of interest (figure
2.11). There were no significant differences in animals’ ability to recall the previous rule
(FLMM(1, 9.926)=0.333, p=0.577, figure 2.11) or TTC (FLMM(1, 8.700)=4.514, 0.064, figure
2.11B). Analysis of perseverative (FLMM(1, 6.784=0.583, p=0.471, figure 2.11C) and
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regressive errors (FLMM(1, 5.725)=0.682, p=0.442) also fails to reveal an effect of LC
stimulation on overall EDS performance. Although there was a significant main effect of
stimulation in decreasing regressive errors (FLMM(1, 5.725)=7.080, p=0.035), stimulation did
so regardless of whether the animal was expressing ChR2 or control virus.
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Verification of Induced Activity by ChR2 and Gq-DREADDs
Failing to see any considerable behavioral effects resulting from optogenetic LC
stimulation during the aSST, additional studies were done to assess the extent to which
these stimulation parameters were able to induce activity in LC. The immediate early
gene c-fos has been extensively characterized due to its elevated translation following
periods of neuronal activation. Levels of its protein product Fos are found to be elevated
to peak levels 90-120 minutes after a period of elevated activity (Dragunow and Faull,
1989; Bullitt, 1990). If ChR2 is producing a sustained period of elevated tonic activity
when stimulation is administered, we would expect to see elevated levels of Fos protein
in tissue fixed 90-120 minutes following the stimulation. The following experiments
attempted to verify the efficacy of ChR2 to elicit activation of c-fos following a 15minute period of 3 Hz stimulation. These experiments also assessed the ability of Gq
coupled Human Muscarinic 3 Designer Receptor Exclusively Activated By Designer
Drugs (hM3Dq, DREADD) to elicit Fos in LC. Comparison of the two methods, albeit
using different histological techniques, indicates the hM3Dq produces a much clearer
picture of induced activity compared to ChR2 in a way that is consistent with a period of
neuronal activation.
Methods: optogenetically stimulated c-fos activation. Following conclusion of
behavioral testing for the aSST rats, they entered a 3 day period of acclimation that
included daily 15 minute sessions in their inactive operant box connected to an FO patch
cable. After 15 minutes they were returned to their homecage. This was done to avoid
non-specific activation of Fos due to novel inactivity of the behavioral apparatus. On the
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fourth day, the rat returned to the operant chamber, and received 15 ms, 5 mW pulses of
light delivered at 3 Hz for 15 minutes. They were then returned to their homecage. These
animals were deeply anesthetized and perfused intracardially with 4% PFA as previously
described 90 after the end of the stimulation session. The brains were post-fixed,
cryoprotected, and sectioned as in previous experiments. One set of sections through LC
was used for each rat.
Laboratory procedures for Fos visualization have been extensively described
(Delfs et al., 1998; Harris et al., 2005; Harris et al., 2007; Mahler and Aston-Jones, 2012;
Sartor and Aston-Jones, 2012). Briefly, Fos was visualized by incubating sections in
rabbit anti-fos (1:5000, Santa Cruz Biotechnology) overnight, then in biotinylated donkey
anti-rabbit secondary antibody (1:500, Jackson ImmunoResearch Laboratories) for 2 h,
and in avidin-biotin complex (ABC, 1:500) for 1.5 hrs. Finally, sections were incubated
in 3,3’-diaminobenzidine (DAB, Sigma) and nickel ammonium sulfate, producing a
purple-black reaction product in the nucleus. These sections were then co-stained with
neutral red to distinguish LC cell bodies from neighboring nuclei. Slides were then
coverslipped and allowed to dry before being photographed at 20X magnification.
Two bilateral sections through LC were used to quantify LC-Fos activation
resulting from optogenetic stimulation. LC cell bodies, which were readily
distinguishable from surrounding nuclei, were counted on each side. Then purple black
nuclei within those cell bodies were counted and Fos was quantified as a percentage of
Fos positive nuclei per LC cell. In animals expressing ChR2 unilaterally, the side
receiving ChR2 stimulation was compared to the non-stimulated side as well as to LC of
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animals who were not expressing detectable levels of ChR2. Bilaterally stimulated
animals were compared to mCherry controls.
Results: ChR2 elicited Fos expression in LC. Samples from animals in the
unilateral stimulation set-shifting were used in this analysis. Histological samples and
quantification of unilateral ChR2 elicited Fos expression in LC is shown in figure 2.12.
Unilateral stimulation failed to significantly increase Fos relative to either the
unstimulated side or to controls not expressing ChR2 (FANOVA(1,52)=0.016, p=0.899).
Histological samples and quantification of bilaterally elicited Fos expression is shown in
figure 2.13. Two of the animals from bilateral aSST experiments were excluded from this
analysis due to loss of implants before the final stimulation could be delivered. Although
group sizes are too small to be properly quantified, it appears that bilateral stimulation
did not increase Fos expression relative to controls.
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Figure 2.12 Unilateral optogenetic stimulation fails to elicit Fos expression in LC.
Unstimlated (A) and stimulated (B) ChR2 animals are shown across the top, and
unstimulated (C) and stimulated (D) control animals across the bottom. Fos expression
for all unilateral animals is quantified in E.
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Having failed to see any robust modulation of Fos expression due to optogenetic
stimulation, subsequent experiments sought to validate hM3Dq as a means to deliver celltype specific stimulation to LC. These Gq coupled receptors can be delivered to LC cells
with viral vectors using the exact methodology previously verified for ChR2 and can be
selectively activated by the otherwise inert ligand clozapine n-oxide (Armbruster et al.,
2007). Using these receptors, the following experiments demonstrate a robust, dose
dependent induction of Fos in LC cells and a significantly correlated induction of Fos in
mPFC.
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Figure 2.13 Bilateral optogenetic stimulation fails to elicit Fos expression in LC.
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Stimulated left (C) and right (D) LC of control animals across the bottom. Fos expression
for all bilateral animals is quantified in E.
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Methods: surgical injection of hM3Dq vectors. Surgical methods follow closely
for those previously described for optogenetics experiments. Notable departures from the
established protocol include differences in the vectors used to deliver hM3Dq to LC cells
as well implanted implements for microinjection of CNO. hM3Dq was delivered using an
adeno-associated virus (AAV) serotype 2/9, expressing the DREADD receptor fused to a
hemagglutanin (HA) tag under the control of the PRSx8 promoter. The control virus was
identical, but only expressed the mCherry reporter protein. Bilateral 28G canulae were
also implanted 1 mm dorsal to the dorsal 1/3 of electrophysiologically localized LC.
These canulae were used in experiments that will be explained in later chapters.
Methods: histological verification of viral expression and Fos induction.
Procedures for tissue fixation and preparation follow from those previously described.
For hM3Dq animals, sections were simultaneously incubated overnight in mouse anti-TH
(1:1000, Immunostar 22941) and rabbit anti-HA (1:1000, Cell Signaling C29F4) in PBST
and 3% NDS. Sections for control animals expressing the mCherry protein were
incubated with the same mouse anti-TH and rabbit anti-DS red (1:500, Clontech 632496).
Donkey anti-mouse Alexa Fluor 488 (1:500, Invitrogen) was used to visualize TH
positive LC neurons; and donkey anti-rabbit Alexa Fluor 594 (1:500, Invitrogen) to
visualize HA-tagged HM3D DREADD receptor expression or control mCherry reporter.
Two-hours and twenty minutes before animals were sacrificed they received a
systemic IP injection of either 1 mg/Kg (hM3Dq n=9 ) or 5 mg/Kg CNO (hM3Dq n=12,
mCherry n=9) dissolved in saline vehicle with 5% dimethyl sulfoxide for induction of
Fos. Sectioning, washing, blocking, and visualization procedures remained the same as
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previously described. LC sections were incubated in mouse anti-TH (1:1000, Immunostar
22941) and rabbit anti-cfos (1:1000 Calbiochem 0148958 or 1:5000 Calbiochem
2441976) in PBST and 3% NDS overnight. Donkey anti-mouse 594 Alexa Fluor 594
(1:500, Invitrogen) was used to visualize TH-positive LC (TH-LC) cells and Donkey
anti-rabbit Alexa Fluor 488 for fos. Fos positive TH-LC cells were counted and
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Results: hM3Dq mediated induction of Fos in LC and mPFC. CNO selectively
and dose dependently increased Fos in LC of hM3Dq animals (Figure 2.14A). In hM3Dq
animals CNO elicited a significant increase in Fos positive LC cells compared to
mCherry controls (FANOVA(1)=52.155, p<0.001). Within-subjects, CNO dose dependently
increased Fos positive LC cells in hM3Dq animals (t(20)=3.448, p=0.002). In PFC, CNO
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Figure 2.15 HM3Dq mediated induction of fos in LC and PFC by CNO. A, Fos
expression (green) in hM3Dq expressing LC by 5 mg/Kg (n=12, top left) and 1 mg/Kg
(n=9, top right) CNO i.p. and by 5 mg/Kg CNO i.p. in mCherry expressing LC
(n=9,bottom left). Quantified in lower right (*p=0.004 compared to 1 mg/Kg hM3Dq). B,
fos induction in PFC of LC hM3Dq animals by 5 mg/Kg (n=12, top left) and 1 mg/Kg
(n=9, top right) i.p. CNO compared to 5 mg/Kg CNO in LC-mCherry animals (n=9,
lower left). Quantified in lower right (*p<0.001, hM3Dq compared to mCherry). C,
correlation of Fos expression in PFC vs. LC in hM3Dq animals (black squares) and
mCherry animals (open squares).
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increased Fos density in hM3Dq animals (FANOVA(1)=19.370, p<0.001) compared to
controls (Figure 1B). However, Fos expression in hM3Dq animals did not differ by dose
(equal variance not assumed, t(19)=1.446, p=0.168). One 5mg/Kg animal was omitted
from this analysis due to PFC tissue damage during brain removal. The proportion of
Fos positive LC cells was closely correlated to the density of Fos expression in PFC
(Figure 2C, R2=0.81, p<0.001).
Discussion
According to adaptive gain theory, optimized set-shifting would be attained with
tonic stimulation immediately following the rule change and properly timed phasic
stimulation as the animal begins to learn and consistently use the new discrimination.
Given these parameters, optogenetic stimulation of LC appeared to be aptly suited to
achieve these requirements. Stimulation could be properly confined to the relevant
behavioral epochs in ways that are unprecedented compared to pharmacological means.
The results of these studies, however, give reasons to reconsider.
Initial proof-of-concept studies showed promise in that ChR2 mediated
stimulation was sufficient to produce a waking response from SWS. However, it was
insufficient to improve performance on the aSST. The only condition in which
optogenetic stimulation did produce an effect was on perseverative errors, within-subjects,
in a single bin of trials, and only on shifts from an unpredictable dimension. Additionally,
the effect size was very small and only barely significant given a one-tailed prediction.
Given the number of comparisons needed to reach this result and the very small effect
size, it is not a finding that elicits a great deal of confidence to inform future study.
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Given that this effect was witnessed with unilateral stimulation of LC, it followed
that bilateral stimulation of LC might bolster and strengthen results going forward. For
instance, if ChR2 stimulation were only exerting tonic control on one LC, the other LC
could potentially remain in the phasic pattern that would be predicted for perseverative
behavior. In this instance, the endogenously active LC could be sustaining the behavior
that ChR2 stimulation is trying to reduce. It was thought that exerting control over both
nuclei might produce the expected effects.
However, the data from the bilateral stimulation experiments do not appear to
support this notion either. Although, this finding may have more to do with practical
concerns related to delivering bilateral stimulation to LC rather than a critical gap in our

A

B

Figure 2.16 Optical implants used for ChR2 experiments. 2.5 mm stainless steel
single ferrules (A) and custom bilateral 1.25 mm ceramic optical ferrules with a
2.4 mm center-to-center distance (B) are shown. Single ferrules required a ML an
AP angle for implantation, considerably decreasing implant accuracy. Bilateral
ferrules allowed for implantation without a ML angle.
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understanding of LC function. The 2.5 mm optical ferrules used for the unilateral
experiments were too large to be implanted parallel to one another as LC is only about
2.4 mm apart. Initial attempts were made to implant these ferrules at a 15° ML angle in
addition to the AP angle used to avoid the transverse sinus. This method proved too
inaccurate to consistently, bilaterally hit LC with these implants. So, a custom bilateral
implant using 1.25 mm diameter ferrules was developed that would not require angled
implantation. These ferules are shown in figure 2.16.
Although considerably more accurate compared to two separate implants aimed at
AP and ML angles, the custom bilateral implants posed their own challenges that may
have contributed to the lack of effects witnessed in the behavioral experiments. The first
design of these implants utilized ceramic ferrules, as seen in figure 2.16B. These ferrules
broke frequently, resulting in loss of animals from experimental procedures. The next
design used stainless steel ferrules that frequently detached from the patch cable over the
course of an aSST session, distracting the animal from the task. All countermeasures to
prevent detachment proved too bulky or were otherwise not well tolerated by the animal.
Generally, tethering to a rat’s head over the course of a sensitive and challenging
behavioral task of long duration may not be a viable strategy with the currently available
hardware.
Implant issues may also be contributing to the lack of effects witnessed for
optogenetic stimulation of Fos production. Even a slight loss of coupling between the
patch cable and optical ferrule over the course of the 15-minute stimulation procedure
would result in a severe attenuation of light output in the LC area. Further, despite taking
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steps to individually calibrate the light source each implant in every animal, there is no
way to verify the appropriate light output over the course of the stimulation session or
behavioral task. Further, any slight variation in the position of the implants, or variation
in the cut of the optical fiber could change the amount of light delivered to the cells. In
this case, activity of a ChR2 expressing cell may go unaffected even though it would
appear that the implant was accurately positioned. Taken together, there is reason for
skepticism that LC was actually receiving the type of stimulation these experiments
attempted to deliver. Verifying light output in the awake, behaving animal either by
combined photonic detection or simultaneous electrophysiological recording could
overcome these practical concerns. However, these approaches would require an even
greater leap in the sophistication of tools currently available for these types of
experiments. A simpler approach could rely on calibrating the light output according to
an independent behavioral outcome, such as waking, to verify what amount of light
would need to be administered to induce the expected levels of activity in LC cells.
Considering electrophysiological response of LC neurons resulting from
optogenetic stimulation raises an additional theoretical concern of whether light pulses
from a single light source is truly mimicking the intended increased tonic activity.
Photons from a single light source would cause any nearby neuron sufficiently expressing
ChR2 to depolarize and fire. This would likely produce a synchronous, pulsatile pattern
in LC neurons superimposed over their baseline activity, which is not the sort of activity
predicted for a tonically active LC nucleus.
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These results are in stark contrast with the ability of CNO activated hM3Dq to
elicit Fos production in LC and a commensurate Fos response in mPFC. These
differences in Fos were very clear, dose dependent, and proportionate, at least insofar as
mPFC is considered. Although, attempts to measure Fos elicited by a microinjection of
CNO in mPFC proved difficult. In such experiments, Fos expression varied widely
throughout mPFC, even across hemispheres in the same animal, in ways that were not
consistent with the treatment given. This may reflect a non-specific activation of this
region resulting simply from the microinjection itself. However, within subject aCSF
treatment would account for any behavioral effects resulting from the microinjection
procedure.
In addition, DREADDs do not require tethering of the animals’ heads to the
behavioral apparatus. This manipulation also preserves typical receptor-ligand
pharmacology that could overcome the synchronous activity possibly brought about by
light based stimulation methods. It is for these reasons that continued experiments sought
to employ DREADD based methods to stimulate LC and its projections to mPFC.
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3.

DREADD MEDIATED STIMULATION OF LC IN SET-SHIFTING
Designer receptors exclusively activated by designer drugs (DREADDs) are a

relatively new research tool developed to provide stimulation, inhibition, or other
modulation to selective neuronal populations. Unlike ChR2, these receptors, having been
modified from endogenous muscarinic receptors, are able to stimulate native G-protien
pathways to produce differing physiological effects within the neuron. This is also done
in a way that preserves typical stochastic receptor/ligand dynamics. This has the
advantage of producing a physiological response that more closely mimics what is
observed in neuronal systems, while still preserving the unmatched specificity confered
by the opsins. This advantage, however, currently comes at the cost of temporal
precision. The experiments that follow in subsequent chapters attempt to confer a small
degree of temporal precision by microinjecting the activating ligand CNO within LC and
mPFC to stimulate NA cells and efferent projections in those areas. This was done with
hopes of confining the period of LC activation to the epoch in which a cognitively
flexible behavioral phenotype would be advantageous on the aSST.
DREADDs were developed with the goal of creating G-protien coupled receptors
(GPCRs) with no demonstrable constituative activity that, when bound by an otherwise
inert small molecule, could activate endogenous signaling pathways. These engineered
GPCRs could then be sequenced, cloned, and packaged into viral vectors for cell
selective expression in neural systems. This would allow for control of G-protein activity
within specific cell types with little to no off-target effects. This goal was achieved

through a process of directed mutagenesis developed by Armbruster and collegues
(Armbruster et al., 2007; Alexander et al., 2009).
To accomplish these goals, mutants of the human muscarinic-3 receptor (HM3)
were grown in yeast and selected for their ability to bind CNO and activate the Gq
signalling pathway. When activated, Gq signaling will result in the production of inositol
triphosphate (IP3). Mutants that produced IP3 in response to CNO were selected and then
subsequently screened for low levels of constituative activity in the absence of CNO. The
mutant Y149C, A239G M3-muscarinic receptor was the first DREADD receptor to fulfill
these criteria. This receptor is simply known as hM3Dq (Armbruster et al., 2007). Other
variants have been developed to directly inhibit (hM4Di) or stimulate (GsD) cyclic-AMP
(cAMP) production and even to interfere with β-arrestin regulation of GPCR trafficking
(Armbruster et al., 2007; Alexander et al., 2009; Sternson and Roth, 2014).
Use of these receptors has lead to a number of high impact confirmatory and
novel findings that were not possible using traditional methods. These include discovery
and identification of feeding circuitry(Aponte et al., 2011; Krashes et al., 2011; Stachniak
et al., 2014), neural substrates of memory encoding (Garner et al., 2012), mechanisms of
synaptic plasticity (Kozorovitskiy et al., 2012; Stachniak et al., 2014), as well as the
neural circuitry of reward-seeking and addiction behavior (Ferguson et al., 2013; Mahler
et al., 2014) to name a few. Most notable for the purposes of the current study has to do
the ability of DREADD mediated Gq signaling to increase activity of LC cells, elicit
changes in arousal as measured by EEG, and facilitate emergence from anesthesia (Vazey
and Aston-Jones, 2014).
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In that study, rat LC was transduced with hM3Dq. Single cell and network
activity was then measured in response to small, microinjected doses of CNO. These
experiments found that in anesthetized animals, a 60 nL dose of CNO increased baseline
discharge and decreased interspike intervals of LC neurons that were expressing hM3Dq
for up to 6 minutes. Additionally, microinjection of 5 µM CNO in LC was sufficient to
increase overall cortical EEG power, reduce burst suppression, and increase theta-band
frequency. Unfortunately, these studies failed to capture a return to baseline following
microinjection of CNO in LC. Nonetheless, both of these results are consistent with an
increase in arousal. Indeed, a systemic dose of CNO was sufficient to decrease latency to
emerge from anesthesia in these animals. This study suggests that microinjected CNO in
LC is sufficient to increase tonic activity of LC cells in a way that is consistent with an
increase in arousal as measured by cortical EEG (Vazey and Aston-Jones, 2014).
The following experiment attempted use microinjected doses of CNO in LC to
transiently increase tonic activity during the behavioral epoch where a flexible behavioral
phenotype would be advantageous in the aSST. This was done under the hypothesis that a
behaviorally flexible state during this epoch would decrease perseverative errors and
improve overall task performance as measured by TTC. However, microinjections of
behaviorally efficacious doses of CNO did not improve overall task performance. Rather,
the high dose produced an increase in regressive responding, suggesting the animal was
unable to consistently follow the new rule.
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pretraining required for each animal and increased baseline levels of perseveration during
EDS testing. This allowed a lower floor for decreases in perseveration to exert a
significant effect. Following side bias testing rats were initially trained to discriminate the
light stimulus dimension. On these trials, all chamber lights are initially off and the levers
are retracted during a 10 s intertrial interval. Then one of the two cue lights, randomly
chosen on every trial, was illuminated for three seconds and remained on until the rat
pressed a lever or the trial timed out after 10 seconds. Once the cue light was on for 3
seconds, the house light was illuminated and both levers were extended into the chamber.
The rat was required to press the lever that was positioned beneath the cue light within 10
seconds to attain reward. If the wrong lever was pressed, the house and cue lights were
extinguished and the levers retracted; this was followed by a 10 second timeout. Rats
were given 200 trials per training session until they were able to reach a streak of 20
correct trials.
Viral Vectors. The two vectors used in this study were cloned and packaged by
the University of Pennsylvania Viral Vector Core. LC specific expression of the HA
reporter tagged Gq coupled HM3D was achieved using the synthetic dopamine betahydroxylase promoter PRSx8 (Abbott et al., 2009). The control vector was regulated
using the same PRSx8 promoter, but only expressed mCherry reporter protein.
Surgical Injection of Viral Vectors and Guide Canula Implantation. Once rats
had completed pretraining procedures, rats underwent surgical procedures for injection of
virus and bilateral LC canulation. These procedures follow closely from surgical
procedures previously described. Only notable departures follow in this description. Four
57

skull screws were affixed to the parietal plates and secured with adhesive luting cement
(C&B Metabond, Parkell). 1.5 µl of the HM3D or control vector was bilaterally infused
over a 100 µm DV extent with brief pneumatic pulses (Picospritzer III, Parker
Instruments) at the physiologically localized LC coordinates and allowed to diffuse
throughout the tissue over 15 minutes before the injector was withdrawn. For LC
microinjection procedures, a 26 gauge double guide canula was lowered 1 mm dorsal
from the DV center of localized LC. One cohort was implanted with 2.4 mm center-tocenter double canula. To allay concerns over leakage of the microinjection into the 4th
ventricle, later cohorts were implanted with 3 mm center-to-center double canula aimed
just lateral to LC. There was no significant interaction on trials to reach criterion between
canula width and treatment (linear mixed model implant width*treatment F=0.063,
p=0.60). The rats were allowed 2 weeks for recovery and virus transduction before
testing resumed.
Extradimensional Strategy Set-Shifting and Microinjection Procedures. Trials
during EDS testing proceeded identically to those in visual cue training. Two types of
EDSs were performed, visual cue shift to spatial response or spatial response shift to
visual cue. REVs were not performed in the following experiments. This was done to
avoid potential confounds resulting from damage due to multiple microinjections. So, to
minimize the number of total microinjections, rats performed only one stimulated and
one unstimulated EDS from the both the unpredictable light dimension and the spatial
dimension for a total of 4 separate EDSs. Only 1 EDS was performed per daily session
(figure 3.2).
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All rats were first trained on the light dimension and then performed an EDS to
the spatial response to the lever opposite their side bias. On the following day, they
performed a spatial response to visual cue EDS. This sequence was repeated on the 2

Rule
Shift
Protocol 1

Cue&Light&

Spa$al&
Lever&
Posi$on&

EDS 1

Cue&Light&

EDS 2

Spa$al&
Lever&
Posi$on&

EDS 3

Cue&Light&

EDS 4

CNO

aCSF

aCSF

CNO

Protocol 2

Figure 3.2 DREADD set-shifting protocols were altered from ChR2 experiments. Rats
performed 4 EDS, 2 from the light dimension and 2 from the spatial dimension. They
received CNO or aCSF according to one of the two protocols to balance possible order
effects.
subsequent testing days (see figure 3.2). Rats received a 300 nl microinjection of either
one dose of CNO (0.1 mM or 0.5 mM in artificial cerebrospinal fluid (aCSF), received
from NIH-NCI NS064882-01) or aCSF counterbalanced over the first two or final two
EDSs. These doses of CNO were determined in a small pilot experiment, similar to that
performed for ChR2 experiments, to be the lowest tested doses sufficient to elicit a
waking response.
On an EDS, the first 20 trials were carried out according to the last rule performed
to criterion. The animal was then removed from the chamber, obturators were removed
from the guide canula, and a 33 G double injector was inserted through and secured onto
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the guide canula so that the injector protruded 1 mm below the guide. Each injector was
connected to a 10 µl Hamilton syringe through polyethylene tubing (PE 20, Becton
Dickinson). The infusion was delivered over 50 seconds and the injectors remained in
place for one minute afterwards. The injector was then removed, the obturators replaced,
and the animal was returned to the behavioral chamber. The initial 10 trials before the
rule change again followed the last known rule. On the 11th trial, without any cueing to
the animal, the rule was switched to the other possible strategy. The animal proceeded to
carry out trials until they were able to execute a streak of 20 correct trials on the new
strategy or until they reached 320 trials. EDSs in which the animal failed to meet criteria
by 320 trials were not included in the statistical analyses. The dependent measures and
statistical analysis thereof follow from the previous section. DREADD animals in these
data were run across three separate cohorts. MCherry animals were run in a separate
cohort and are compared separately.

Results
For the first 20 trials of a set-shifting session, the rat was required to follow the
last rule previously performed with all rats being initially trained to accurately perform
the visual cue rule. If the rat had last performed a visual cue shift to spatial response EDS,
the following EDS would begin with 20 trials on same spatial response rule and viceversa. There were no within or between-subjects baseline differences on this first 20 trial
block (Figure 3.3A, FLMM(3,54.870)=0.877, p=0.459). Following this first 20 trial block, rats
were removed from the behavioral chamber and given microinjections of CNO (0.5 mM
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or 0.1 mM) or aCSF and then carried out another 10 trials on the initial rule. Again, there
were no between or within-group differences in the animals ability to continue to utilize
the known rule following microinjection (Figure 3.3B, FLMM(3, 41.308)=2.686, p=0.059). On
the 11th trial following microinjection, the strategy-rule changes and the rat must shift its
strategy to continue to receive reward on every trial and trials continue under the new
rule until the rat reaches a streak of 20 correct trials. Trials to criterion were significantly
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Figure 3.3 Strategy set-shifting results indicate hM3Dq mediated stimulation from a 0.5
mM injection of CNO in LC increases regressive responding within subjects (clustered
bars). Proportion of correct trials preceding rule change before (A) and following (B)
microinjection of aCSF (grey bars) or CNO (black bars). (C), total trials to reach criterion
following rule change (*p=0.003). Breakdown of errors by perseverative (D), regressive
(E, *p=0.001), or non-perseverative (F) error commission.
increased between subjects in the 0.5 mM group compared to the 0.1 mM group (Figure
3.3C, FLMM(3,35.337)=5.553, p=0.003). However, no significant within-subjects differences
were seen to result in this group from treatment with CNO (LSD(38.545)=21.747 ± 12.859,
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p=0.099). Error analysis revealed no significant main effects on perseverative (Figure
3.3D, FLMM(3, 41.908)=0.571, (E) (*p=0.001), and non-perseverative (F). However,
regressive responding was significantly increased by 0.5 mM CNO (Figure 3.3E, FLMM(3,
33.930)=6.397,

p=0.001) within-subjects (LSD(37.538)=6.609 ± 2.571, p=0.014). Omissions

did noti differ significantly as a result of CNO treatment (FLMM(3, 47.350)=1.621, p=0.197,
Figure 3.5A)
The mCherry control group was tested as an entirely separate cohort so is, thus,
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Figure 3.5 EDS omissions in hM3Dq (A) and mCherry (B) animals do not differ as
a result of CNO treatment.
statistically compared independently from hM3Dq animals. Treatment with the 0.5 mM
dose of CNO seen to be effective to increase regressive responding in hM3Dq animals
produced no significant differences on any of the same measures. Accuracy prior to
(Figure 3.4A, FLMM(1, 23.559)=0.000, p=0.983) and following (Figure 3.4B, FLMM(1,
23.107)=0.665,

p=0.423) microinjection, and trials to criterion (Figure 3.4C, FLMM(1,

14.379)=4.333,

p=0.056) did not statistically differ within subjects. Error commission was

also statistically equal for perseverative (Figure 3.4D, FLMM(1, 15.212)=0.373, p=0.550),
regressive (Figure 3.4E, FLMM(1, 15.954)=0.892, p=0.359), and non-perseverative (Figure
3.4F, FLMM(1, 19.125)=0.328, 0.573) error types. Omissions did not differ significantly as a
result of CNO treatment (FLMM(3, 5.346)=0.822, p=0.404, Figure 3.5)
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To determine if the lack or presence of treatment effects in hM3Dq animals may have
been due to order effects, that is that EDS performance may only be influenced by CNO
treatment on the first EDS performed, the data from the first EDS performed was
analyzed separately (Figure 3.6). Of the 10 total animals in the 0.1mM dose group, 4
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Figure 3.6 No significant differences in performance result from CNO treatment when only
the first EDS are compared. Proportion of correct trials preceding rule change before (A)
and following (B) microinjection of aCSF (grey bars) or CNO (black bars). (C), total trials
to reach criterion following rule change. Breakdown of errors by perseverative (D),
regressive, or non-perseverative (F) error commission.
received aCSF and 6 CNO, while 3 and 7 animals in the high dose group recieved aCSF
and CNO respectively. There were no signficant differences in this first shift analysis,
although the trend toward increased regressive behavoir appears to be present as this
initial timepoint. There were no differences in pre-shift performance prior to (FANOVA(3,
16)=0.884,

p=0.470) or following (FANOVA(3, 16)=2.317, p=0.114) microinjection. TTC
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(FANOVA(3, 16)=1.677, p=0.212), perseverative errors (FANOVA(3,16)=0.165, p=0.918),
regressive errors (FANOVA(3,16)=1.732, p=0.201) and non-regressive errors
(FANOVA(3,16)=0.668, p=0.573) were also not significantly changed by treatment with
CNO.
Discussion
HM3Dq mediated stimulation of LC failed to decrease perseverative errors and
did not improve animals’ overall performance on the aSST. This result fails to support
the hypothesis that tonic LC activity actively induces a cognitively flexible state that
would facilitate set-shifting behavior. What is witnessed is an increase in regressive
responding, or failing to consistiently utilize the new behavior once it has been
discriminated. These errors occur later in the set-shifting session, which may indicate that
LC is remaining tonically active for a period that extends into the expression phase of the
new rule. However, that it would affect late regressive behavior without affecting early
perseverative behavior might give reason to question if this is the case.
Previous studies using this task have been able to induce increases in
perseverative behavior with varying manipulations. For instance, blockade of PFC
GABAA receptors with bicuculline selectively increased perseverative errors (Enomoto et
al., 2010). Similarly, blockade of GluN2B NMDA receptors with Ro25-6981 did the
same (Dalton et al., 2011). But, to date, no experiments have attempted to reduce
perseverative behavior and facilitate performance on this task. So it is unclear whether it
is possible to further reduce perseverative behavior below baseline levels typically seen
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in this task. However, once perseveration has ceased, prolonged tonic activity may be
impairing the animals’ ability to determine and consistently utilize the new rule.
VTA dopamine (DA) neurons are also well known for patterned tonic and phasic
activity that is thought to be related to set-shifting behavior. This relationship has been
modeled as is relates to sharp changes in network activity in PFC neurons (Durstewitz
and Seamans, 2008; Durstewitz et al., 2010). Since the manipulations in the present
experiments are specific for LC, VTA would likely continue to operate in accordance
with the task demands. Therefore, even though hM3Dq stimulation is able to induce a
tonic mode of LC activity, phasic release of dopamine may continue in a task-relevant
way beyond the rule change trial. This could continue to support perseverative behavior
until VTA neurons endogenously switch their pattern of activity. It may be necessary to
exert a measure of control over both nuclei in order to fully optimize behavior on this
task.
Stimulation of LC by CNO did induce an increase in regressive behavior, a
behavioral output that occurs later in an EDS session when CNO levels at the site of
injection would be expected to diminish. Notably, this effect is apparent on the very first
EDS when CNO is received, although between subjects comparisons at this time point
likely have too few observations to achieve signficiance. It is noteworthy then that the
full time course of microinjected CNO induced activity remains to be determined. Prior
reports have shown that activity of LC cells is elevated for up to 6 minutes by a 60 nl
microinfusion of CNO administered within the LC. Similarly, microinjection of 5 µl
CNO into LC produced a rightward shift in cortical EEG and an increase in theta band
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frequency. However, in addition to considerable differences in dosage, those data failed
to capture a return to baseline (Vazey and Aston-Jones, 2014). An alternative explanation
could be that increased tonic activity early in the EDS may be preventing updating of a
new behavior. So, although the animal has realized the previous behavior is no longer
relevant, alternative strategies have not been adequately formed. This could still manifest
as an increase in regressive responding that lags behind the point at which CNO would be
exerting its effects. Whatever the proper interpretation may be, a more thorough time
course analysis of CNO elicited activity of cells in PFC resulting from stimulation of LC
inputs would be required before direct comparisons between early and late session
behavioral outputs could be made.
Another possible reason for the increase in regressive responding may result from
stimulation of other LC pathways. It is worth noting that complete expression of hM3Dq
was not achieved throughout LC in any animal. Under these conditions, it is almost
certain that the extent and pattern of viral transduction differed in each animal. While LC
projections to mPFC are necessary in set-shifting, limbic projections play a well-known
role in memory retrieval and consolidation (Murchison et al., 2004; Sterpenich et al.,
2006; Sara, 2009; Sara, 2010). Enhanced memory retrieval would likely favor the old
strategy from which the animal is being shifted. It is possible that variation in viral
expression patterns between animals is masking effects by exerting differing degrees of
stimulation between prefrontal or limbic targets in each animal.
It follows then, that manipulations of NA activity outside of the context of
behavioral inputs may need to be regionally selective in addition to cell specific and
67

temporally precise. Recent studies have demonstrated that CNO microinjected at terminal
sites of infected nuclei is sufficient to modify activity within the target region and induce
relevant behavioral outcomes (Mahler et al., 2014; Stachniak et al., 2014; Vazey and
Aston-Jones, 2014). Therefore, it might follow that selective stimulation of LC efferents
within the mPFC could induce the flexible behavioral phenotype sought in these
experiments that would lead to enhanced set-shifting performance.
The experiments outlined in the following chapter sought to selectively stimulate
hM3Dq expressing LC terminals in the PFC by microinjecting CNO directly at the
intended site of action. In doing so, any potential interference resulting from stimulation
of the whole LC nucleus, or different subsets thereof that would facilitate memory
retrieval, would be eliminated. The resulting data should provide the clearest possible
result to speak to the sufficiency of LC inputs into PFC and their role in set-shifting
behaviors.
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4.

STIMULATION OF LC INPUTS TO PFC IMPROVES SET-SHIFTING
The LC-NE system sends broad projections throughout the telencephalon with

differing efferent density and heterogeneous patterns of target receptor expression.
Depending on the site of action, NA manipulation can play varying roles in an array of
behavioral phenomena (Aston-Jones et al., 2000; Sara, 2009; George et al., 2012; Carter
et al., 2013; Hickey et al., 2014). Also, within the LC itself there is a fair degree of
heterogeneity such as in CRF innervation, kappa-opioid receptor expression (Van
Bockstaele et al., 2001) and nociceptive properties (Hickey et al., 2014). So, perhaps it is
not surprising that exogenous stimulation of this system may need to be regionally
specific in order to elicit the behavior profile set forth by adaptive gain theory.
Recent studies have found that microinjections of CNO within distinct target
regions are sufficient to elicit local modulation of activity and modify behavioral
responses (Mahler et al., 2014; Stachniak et al., 2014). Stachniak et al., 2014 examined
the synaptic activity of locally administered CNO on hM4Di expressing pyramidal cells
also co-expressing ChR2. They reported that CNO effectively silenced synaptic release
from these cells even though pulses of light were sufficient to elicit action potentials in
the axon of the same cells. Extending this finding, they expressed hM4Di in the
periventricular nucleus of the hypothalamus and administered CNO locally within target
areas to map out the selective contributions of PVH inputs in order to assess the selective
roles of these regions in mediating feeding behavior. Using a similar approach, Mahler,
et al. 2014 expressed hM4Di in rostral ventral pallidum (RVP) neurons to assess their
role in modulating VTA and cocaine self-administration. Local administration of CNO in
the VTA of rats expressing hM4Di in RVP neurons revealed a divergent response of

VTA neurons with putative DA neurons becoming excited, while other faster spiking
cells were inhibited. When CNO was locally administered before cocaine selfadministration in these same animals, cue-induced reinstatement of cocaine seeking was
blocked. Taken together, there is reasonable evidence that locally administered CNO
would be efficacious to produce local stimulation of LC terminals within the PFC.
The experiments in this chapter used locally administered CNO to stimulate LC
terminals in the mPFC to test their sufficiency to improve set-shifting performance on the
aSST. This approach follows very closely to the methods put forth in chapter 3, with the
only major exception of CNO administration within mPFC rather than LC. Using this
approach, these experiments find that CNO indeed reduced TTC. However, this
improvement was not associated with a reduction in perseverative errors. Rather, it was
driven by a reduction in regressive errors. Further, this reduction in regressive errors
appears to result from enhanced application of the new rule being discriminated rather
than a precipitous shift away from the old rule.

Methods
Most experimental methods follow directly from chapter 3 with few exceptions. Notable
differences are as follows. Following injection of viral vectors in LC, the craniotomy was
filled with sterile Gelfoam (Pfizer). Two smaller holes were drilled for PFC canulae.
Bilateral 26 gauge guide canula were implanted at AP +3.2, ML ±0.7, DV -3.2 as
measured from bregma and top of skull. Although all implants were accurately located
within prelimbic (PL) cortex, initial cohorts showed considerable anterior movement over
the course of the 3 month post-surgical period. Later cohorts were implanted at AP 2.7
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from bregma. All implants of animals included in these analyses were contained within
PL or infralimbic (IL) cortex. 18 total animals, 9 hM3Dq and 9 mCherry animals with
confirmed bilateral virus expression and accurate canulae within PL/IL were used for
these procedures. HM3Dq and mCherry animals were each tested in separate cohorts, so
are statistically compared separately.
Following surgery, animals were allowed 1 month for recovery and virus
expression. Pretraining procedures began after this one-month period. EDS testing did
not begin until two-months following virus injection to allow for trafficking of viral
products to the PFC.
Verification of viral expression in LC follows directly from previous chapters. In
addition to verifying expression at LC, expression of hM3Dq and mCherry was also
verified in PFC sections. One set of 40 µm PFC sections was reacted in mouse anti-HA
(1:1000) to label tagged hM3Dq or in rabbit anti-DSRed (1:1000) to label mCherry
expression. hM3Dq expression was visualized with donkey anti-mouse Alexa Fluor 594
(1:500) and mCherry was visualized with donkey anti-rabbit Alexa Fluor 594 (1:500).
These procedures also incorporated a win/stay, lose/shift analysis to measure
choice behavior following correct or incorrect trials. To do this, choice on a given trial
was compared to the stimuli presented and outcome of the previous trial. If the animal
chose the lever associated with the correct behavior on the previous trial, that trial was
counted as a win/stay. If the animal chose the opposite lever from the one associated with
the incorrect behavior on the previous trial, this was counted as a lose/shift. This was
calculated as a proportion of win or loss trials, respectively. Win/stay and lose/shift
behavior was analyzed for the first bin of 25 trials following the rule change as well as
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Expression of hM3Dq (Figure 4.1A) and mCherry (Figure 4.1B) in mPFC was
verified in animals with confirmed transduction of viral proteins in LC. Accurate bilateral
canulae placements for the 18 animals utilized is shown in figure 4.1C. Performance of
the known rule did not differ before (Figure 4.2A, FLMM(1, 23.001)=1.812, p=.191) or
following (Figure 4.2B, FLMM(1, 14.996)=0.010, p=0.920) administration of aCSF or 0.5 mM
CNO. Microinjection of CNO in PFC reduced TTC within-subjects (Figure 4.2C, FLMM(1,
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Figure 4.2 HM3Dq mediated stimulation of LC efferents in PFC resulting from
microinjection of 0.5 mM CNO decreases TTC as a result of decreased
regressive responding. Proportion of correct trials preceding rule change before
(A) and following (B) microinjection of aCSF (grey) or CNO (black). C, total
trials to reach criterion following rule change (*p=0.025). Breakdown of errors
by perseverative (D), regressive (E) (*p=0.012), and non-perseverative (F).
16.469)=6.128,

p=0.025). Analysis of error types reveals that this reduction in TTC is

associated with a decrease in regressive errors (Figure 4.2E, FLMM(1, 20.583)=7.658,
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p=0.012) while perseverative (Figure 4.2D, FLMM(1, 15.263)=0.569, p=0.462) and nonperseverative error commission (Figure 4.2F, FLMM(1, 17.770)=0.715, p=0.409) were
unchanged. Omissions did not differ by CNO treatment (FLMM(1,8.820)=1.050, p=0.753,
figure 4.4).
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Figure 4.3 Microinjections of 0.5 mM CNO in PFC produce no effects in mCherry
controls. Proportion of correct trials preceding rule change before (A) and following
(B) microinjection of aCSF (grey bars) or CNO (black bars). C, total trials to reach
criterion following rule change. Breakdown of errors by perseverative (D), regressive
(E), and non-perseverative (F).
To attempt to determine the ways in which set-shifting performance was altered
by CNO in the hM3Dq animals an analysis of win/stay and lose/shift performance was
conducted. This measures how consistently the rat applies a successful strategy following
rewarded trials (win/stay) or applies a different strategy following punished trials
(lose/shift). At an early time point immediately following the rule change, there is no
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Difference in win/stay performance (Figure 4.4A, FLMM(1, 22.319)=1.1312, p=0.294) as a
result of CNO treatment. However, lose/shift performance is slightly decreased (Figure
4.4B, FLMM(1, 14.025)=4.643, p=0.049) at this same time point as a result of CNO treatment.
At a later time point preceding the last bin of trials in which the animal meets criterion,
win/stay performance is significantly increased by CNO (Figure 4.4C, FLMM(1,
13.276)=6.427,

p=0.025) while lose/shift performance is unaffected (Figure 4.4D, FLMM(1,

11.657)=1.401,

p=0.260).

To determine if the lack or presence of treatment effects in hM3Dq animals may
have been due to order effects, that is that EDS performance may only be influenced by
CNO treatment on the first EDS performed, the data from the first EDS performed was
analyzed separately (Figure 4.6). Of the 9 total animals in the 0.1mM dose group, 7
received aCSF and 2 CNO. On the very first shift, despite small group size, TTC was
signficantly decreased at this timepoint when animals received CNO. Regressive errors
were similarly decreased as in the full analysis, although not significantly. There were no
differences in pre-shift performance prior to (FANOVA(1, 7)=0.003, p=0.956) or following
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(FANOVA(1, 7)=0.119, p=0.741) microinjection. TTC was signifcantly reduced as a result of
CNO treatment (FANOVA(1, 7) 8.437, p=0.023), while perseverative errors
(FANOVA(1,7)=0.002, p=0.962), regressive errors (FANOVA(1,7)=2.772, p=0.140) and nonregressive errors (FANOVA(1,7)=0.5444, p=0.052) were not significantly changed by
treatment with CNO.
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Figure 4.5 HM3Dq mediated stimulation of LC efferent terminals in PFC
decreases lose/shift performance after the rule change and increases win/stay on
later trials. Proportion of win/stay (A) and lose/shift (B, *p=0.049) performance
for 25 trials immediately following the rule change. Proportion of win/stay (C,
*p=0.025) and lose shift (D) performance on a 25 trial bin preceding the final bin
in which criterion was met.
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Figure 4.6 First EDS analysis reveals significant reduction in TTC resulting from
treatment with CNO. Proportion of correct trials preceding rule change before (A)
and following (B) microinjection of aCSF (grey bars) or CNO (black bars). (C), total
trials to reach criterion following rule change (*p=0.023). Breakdown of errors by
perseverative (D), regressive, or non-perseverative (F) error commission.

Discussion
DREADD mediated stimulation of LC efferent terminals in mPFC is sufficient to
improve overall set-shifting performance. HM3Dq expressing rats required fewer trials to
reach criterion on EDSs following an mPFC microinjection of CNO compared to EDSs
where aCSF was administered. This effect is even evident when only data from the first
EDS is compared. Control animals expressing mCherry required equivalent TTC
regardless of the treatment received. Average TTC witnessed in control animals was
similar to what was seen in hM3Dq animals receiving aCSF. The improved performance
was associated with a significant decrease in regressive errors while none of the other
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error types differed by treatment. Further, the decrease in regressive responding appears
to arise from an enhancement of win/stay behavior late in the EDS session rather than an
increase in lose/shift behavior. In other words, the decrease in regressive responding
appears to result from more consistent application of the new rule once it has been
discriminated rather than a more rapid abandonment of the old rule.
As in the previous chapter, these experiments find a significant effect of CNO on
regressive responding rather than perseverative errors. However, instead of increasing
regressive responding, as was the case for LC microinjection studies, CNO decreased
regressive errors, resulting in a decrease in TTC. The lack of effect on perseverative
behavior, again, might suggest that tonic stimulation of LC does not actively induce a
cognitively flexible phenotype that would immediately shift responding from a learned
behavior. However, this interpretation may be overly simplistic, relying on a number of
assumptions that have not been tested in this framework.
First, this interpretation of the data presumes that NA is the only modulatory
influence in play for the behavior being tested. As was established previously, patterned
activity of DA neurons also exerts considerable influence on the persistence of rewardseeking behavior. By only exogenously controlling NA activity in mPFC, DA cells are
left free to fire according to endogenous parameters. If this were the case, endogenous
DA activity within reward circuits may be enough to sustain perseverative behavior
regardless of the activity of NA terminals in mPFC. In order to induce the optimal state
of cognitive flexibility that would further facilitate performance on this task, it may be
necessary to exogenously control inputs from multiple areas within mPFC.
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It is entirely possible that this test may not be sensitive to a reduction in
perseveration due to a floor effect. Recall that previous studies using this task have been
able to induce increases in perseverative behavior with varying manipulations (Floresco
et al., 2008; Enomoto et al., 2010; Dalton et al., 2011) but have not reported reductions of
this behavior within the same paradigm. Additionally, tasks probing stronger habitual
behaviors have been able to reduce habitual responses by perturbing mPFC activity
(Smith et al., 2012). In this experiment, rats were over trained on a T-maze task that
required them to turn a particular direction in response to an auditory cue. Performance of
the behavior persisted in control rats even following a period of reward devaluation,
confirming the habitual nature of the learned response. By optically inhibiting IL cortical
neurons, the experimenters were able to achieve a reduction in perseverative behavior
(Smith et al., 2012). Overtraining was expressly avoided in the present study. So it may
not be possible to further reduce perseverative behavior below baseline levels typically
seen in this task without a incorporating a stronger habitual component.
What is clear is that performance on this set-shifting task is improved with
stimulation of LC terminals in mPFC and that this improved performance is associated
with a decrease in regressive responding. There are two possible behavioral outcomes
that could produce this effect, 1) more rapid abandonment of the old rule and/or 2) more
consistent application of the new rule once it has been discriminated. The win/stay
lose/shift analysis speaks to this difference. Evidence for outcome 1 would manifest as an
increase in lose/shift behavior, which is choosing the alternate strategy more frequently
following an incorrect trial. Evidence for outcome 2 would manifest as an increase in
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win/stay behavior, or choosing to respond with the same strategy following a successful
strategy. What is witnessed is an increase in win/stay behavior in the 25 trails preceding
the block of trials in which the animals achieved a 20 trial streak. An increase in
lose/shift behavior is not seen at this time point. These results would suggest that the
improved performance resulting from decreased regressive responding is due to an
enhanced ability to consistently apply the new rule.
Set-shifting and behavioral flexibility are multi-faceted behaviors incorporating
an array of cognitive abilities (Floresco and Jentsch, 2011). Facilitation of any one of
these processes, such as response inhibition, extinction, or acquisition of the new
response could improve overall performance on this task. Blockade of the norepinephrine
transporter has been shown to improve inhibition of a pre-potent response (Bari et al.,
2009). Likewise, there is a considerable literature on the role of PFC beta-adrenergic
receptors in the facilitation of extinction (Mueller and Cahill, 2010). So, the behavioral
facilitation seen here is likely to result from an enhancement of a set of inextricably
linked cognitive processes. In addition to noradrenergic input, influence exerted by coreleased dopamine (Devoto et al., 2001; Devoto et al., 2005), glutamate (Fung et al.,
1994), or peptides such as galanin (Holets et al., 1988) cannot be ruled out. Co-infusion
of CNO with antagonists for each synaptic target could parse the selective contributions,
if any, of non-noradrenergic sources to this behavior.
Antidromic stimulation of LC cells projecting to mPFC could also contribute to
this effect. Although the extent to which hM3Dq can produce antidromic depolarization
remains to be established, it cannot be eliminated as a possible source of this response.
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Within the PFC, there is evidence of selective innervation of discrete cortical sub-regions
by individual LC cells (Chandler and Waterhouse, 2012). However, longstanding
evidence suggests that a single branching LC cell can innervate multiple discrete targets
throughout the forebrain (Moore and Bloom, 1979) in non-uniform patterns (Agster et al.,
2013). So, although we can be reasonably confident that alternative afferent stimulation
would be fairly limited within PFC, it cannot be ruled out for other known LC targets.
However, due to the degree of specificity within PFC, it may be reasonable to assume
that stimulation confined to PL/IL cortex would likely be stimulating and recruiting
alternative afferents within the same network that contributes to improved performance
on this task. Techniques combining terminal based stimulation and electrophysiology
would be required to determine the degree to which antidromic activity could be
contributing to this effect.
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5.

DISCUSSION
These experiments were designed to directly test specific tenets of adaptive gain

theory. This theory posits that distractibility and focused attention are conserved
behaviors that exist along the same continuum. Further, patterned tonic or phasic activity
of the LC has a direct influence on the degree of distractibility or focus an individual is
able to attribute at a given time. Specifically, when a behavior is of high utility, LC fires
in a task-dependent phasic pattern that increases gain within the appropriate telencaphalic
networks. This is thought to facilitate ongoing performance of the relevant behavior to
exploit the rewarding opportunity. However, as the utility of a given behavior begins to
wane, phasic activity becomes attenuated and baseline tonic activity is elevated. This
switch is thought to bring about an adaptive disengagement from the ongoing behavior
that would facilitate exploration of new, more rewarding opportunities. The experiments
detailed herein sought to exogenously induce a pattern of tonic stimulation within LC and
its targets in the mPFC to test if these manipulations would improve performance on a
strategy set-shifting task.
There is a well-established literature, detailed previously, on the necessity of LC
projections to the mPFC in set-shifting behavior (Birrell and Brown, 2000; Tait et al.,
2007; McGaughy et al., 2008). The current experiments attempted to test the sufficiency
of tonic stimulation within this circuit to improve performance on an operant set-shifting
task (Floresco et al., 2008) by inducing a flexible behavioral phenotype that would
disengage rats from a given behavior immediately following a rule change. Given these

assumptions, properly timed tonic stimulation of LC or its efferent inputs to mPFC
should reduce overall TTC on this task. Further, if this manipulation is directly causing a
disengagement from a behavior that is no longer relevant, a reduction in perseverative
errors should be detected.
The primary findings of this study suggest that tonic stimulation of LC efferent
inputs to mPFC is sufficient to reduce TTC and improve performance on the aSST.
However, these manipulations were not sufficient to reduce perseverative errors. Rather,
this manipulation produces the expected effect by reducing regressive responding.
Analysis of trial outcome and subsequent choice behavior suggests that this effect results
from an enhanced ability of the animal to consistently follow a new rule once it has been
discriminated rather than by facilitating a more precipitous switch away from the old
strategy. This effect was not witnessed when stimulation was confined within the LC
nucleus itself, which may reflect differing functional roles of separate LC targets in this
paradigm.
These experiments first required determination of an appropriate method to
deliver cell-specific and temporally precise exogenous stimulation to LC. Given its
unmatched temporal precision, initial efforts to carry out these experiments attempted to
employ optogenetically-mediated stimulation to induce tonic firing in LC cells. Initial
pilot results indicated that optogenetic stimulation of LC was efficacious in producing
network wide changes in activity as well as an arousal and waking response in a sleeping
animal. However, it does not appear that optogenetic stimulation was efficacious in
modifying behavior in this task, except under highly specific circumstances and with very
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small effect. Optogenetic stimulation also failed to produce any significant Fos induction
compared to controls as it was administered here.
In contrast, hM3Dq mediated stimulation was able to produce a robust induction
of Fos compared to mCherry controls. This effect was CNO dose dependent within the
LC and positively correlated to Fos induction within the mPFC. Further, the two
microinjected doses of CNO were sufficient to produce a similar waking response in
hM3Dq pilot animals that was not seen when aCSF was administered. So, given that
DREADD mediated stimulation was able to produce expected behavioral outcomes as
well as an induction of an activity dependent molecular marker, it appeared to be a better
candidate for these experiments.
These differences may reflect little other than practical issues with administering
optogenetic stimulation within this framework. Canulae based methods have the
considerable advantage of allowing for verification of light output both before and after a
behavioral session. However, it is very difficult to insert these fibers through guide
canulae without damaging them and any slight damage can result in a considerable loss
of light output. Further it is not favorable to sedate the animal immediately prior to a
challenging cognitive behavioral assay. Permanently implanted ferrule based systems
subvert this latter concern, being easily attached without damage. However, it becomes
impossible to verify light output at the source once the ferrule has been implanted. Future
studies may do well to individually calibrate light output for each animal according to an
independent behavioral measure, such as waking, rather than using a consistent output in

84

every animal. This could also help compensate for individual differences in levels of
virus expression or slight variations in placement or angle of the implant.
One concern this approach would not address has to do with tethering of the
animal by the head during the behavioral task. Often, FO cables would become detached
from the animals implant, or otherwise distract the animal from the task. It was clear in
observing animals’ behavior throughout the task that they would often rear or reach back
in order to grab or bite the cable. This behavior was occurring while the aSST was
running. So, it is hard to conclude that data in those experiments provided a clear
assessment of set-shifting behavior. Further, if the cable became detached, the animal
would typically chew or otherwise attend to the cable rather than executing the task in a
focused manner. This is compounded by the fact that even a small separation in coupling
of the ferrule ends could severely attenuate light output of the implant.
Ultimately, all of these concerns are practical and should be addressable with
advancements in the available technology. The countermeasures employed in these
experiments proved either ineffective to combat these issues or were not well tolerated by
the animals. Advancements in technology employing, ultra-lightweight, multi-parametric,
wireless implants with multiple light outputs (Boyden, 2011; Kim et al., 2013) may help
to overcome these issues. However, the experimental questions resulting from these
techniques are currently outpacing the technology readily available to answer them.
Although lacking the temporal precision of ChR2, DREADD technology does not
require any considerable technical advancement beyond basic tried-and-true behavioral
pharmacology. It was for all of these reasons that this method seemed a viable alternative
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for providing exogenous stimulation to LC. Indeed, this shift in methodology proved
fruitful for answering our experimental questions.
Microinjections of CNO within hM3Dq expressing LC did not improve overall
performance of the aSST as measured by TTC. The animals in the high dose group did
require significantly more TTC, but this did not differ by the treatment received, either
aCSF or CNO. So, this likely only reflects a difference in baseline performance of the
task in these animals. However, when CNO was administered in the mPFC where LC
terminals were expressing hM3Dq, EDS performance was improved within subjects
compared to aCSF. Further, this effect was not witnessed in animals expressing only the
mCherry reporter protein, whose TTC in both treatment conditions compares more
closely to aCSF hM3Dq animals.
A similar site-specific divergent response was also witnessed on regressive errors.
In hM3Dq animals receiving 0.5 mM CNO in LC, regressive errors were significantly
increased compared to all other treatment conditions and groups. But, when the same
dose of CNO was administered in the mPFC, regressive errors were decreased. Moreover,
it is this decrease in regressive errors that underlies the improved overall performance
seen in these animals.
These results would appear to indicate underlying qualitative differences in these
two approaches, that is stimulation of the nucleus as a whole versus stimulation of a
specific target area. One possible explanation for this divergent effect may have to do
with the broad projection of LC processes throughout the telencephalon and the varying
roles of the regions receiving this innervation. Within the mPFC, input from the LC is
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necessary for (Birrell and Brown, 2000; Tait et al., 2007; McGaughy et al., 2008;
Newman et al., 2008) and sufficient to improve (current data) set-shifting performance.
However, within limbic circuitry, noradrenergic input plays a very well established role
in the retrieval and reconsolidation of memories (Murchison et al., 2004; Sterpenich et al.,
2006; Sara, 2010). Thus, when CNO is administered within the LC, it could be
stimulating cells projecting to these or any other targets of the nucleus. Further, full
bilateral transduction of virus was not achieved in any animal. So it is likely, if not
certain, that different cells received different degrees of stimulation when CNO was
administered locally in LC. This could result in a diversity of response in terms of
performance on the aSST, potentially washing out any improvement in performance that
may have been witnessed otherwise. The current results might even suggest that, in this
group of animals, limbic projections were inordinately stimulated since an increase in
regressive responding was measured. However, when CNO was administered only in
mPFC, this competing drive was eliminated and the improvement in performance was
realized.
It has also recently become clear that DREADDs may be working differently in
the synapse than at the soma. Studies using the inhibitory Gi coupled human muscarinic4 DREADD (hM4Di) have shown varying physiological effects depending on where
CNO was administered. When administered at the soma of hM4Di expressing cells, CNO
causes hyperpolarization but is unable to consistently prevent generation of action
potentials (Ferguson et al., 2011; Krashes et al., 2011). However, when CNO is
administered at hM4Di expressing terminals, it potently suppresses release of
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neurotransmitter in an action potential independent manner (Stachniak et al., 2014). It is
yet unclear whether hM3Dq would exert similar differing effects depending on the site of
CNO administration. Perhaps CNO binding to hM3Dq receptors at mPFC LC terminals
results in increased presynaptic calcium or activation of protein kinase C that would
facilitate release of neurotransmitter regardless of action potential generation in the axon.
In this case, tonic levels of synaptic NA would remain elevated, even if phasic activity
persisted in LC in a task relevant pattern. In other words, NE release from these
terminals onto mPFC synapses would more closely mimic a physiological tonic mode in
the presence of CNO even if phasic impulse activity persisted in LC in response to the
task conditions. These noted differences in site-specific actions of DREADD receptors
could play a role in the divergent behavioral responses reported here.
There is also potential that this stimulatory effect may not remain isolated within
the mPFC. If Gq activity in presynaptic terminals is increasing local calcium
concentration, either by release of intracellular stores or PKC dependent regulation of ion
channels, it follows that the resulting depolarization could activate voltage-gated
channels leading to back-propagating action potentials. Although generation of backpropagating depolarization by hM3Dq mediated stimulation has yet to be demonstrated, it
cannot be ruled out as a factor by these experiments. According to the published literature,
all but a small percentage of LC cells will innervate a single discrete subregion of PFC
(Chandler and Waterhouse, 2012). However, there is considerable evidence that a single
LC cell can branch and innervate multiple subcortical structures (Moore and Bloom,
1979). These sites of subcortical innervation can vary greatly in the expression of synapse
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forming varicosities (Agster et al., 2013). It follows then that alternative afferent
stimulation would be limited within mPFC, so it is unlikely that other PFC sub-regions
would be directly contributing to this effect unless directly stimulated by CNO. But, this
assumption does not hold for other non-cortical LC targets that may share branching
axons with terminals in mPFC. It may be the case that common subcortical targets
recruited by this type of stimulation are part of a relevant behavioral network that
mediates performance on this task. Therefore, although alternative afferent stimulation
may be antidromically recruiting additional subcortical regions, it could be doing so in a
network specific manner that enhances performance on this behavioral assay. However,
when stimulation is delivered to somato-dendritic regions, the enhanced LC activity may
modify activity across multiple networks, some of which could potentially support
performance of the old rule even after the reward contingencies have changed.
If these effects do indeed result from action potential independent mechanisms, it
calls into question how exactly Gq mediated stimulation is modifying activity of LC cells.
Based on in-vivo recordings, these experiments assumed that CNO would simply
increase of baseline activity of hM3Dq expressing LC cells (Vazey and Aston-Jones,
2014). Presuming that increased tonic activity would lead to a flexible behavioral
phenotype, it was hypothesized that perseverative errors would be reduced as a result of
an active disengagement from the previously relevant behavior. This was not witnessed
for any experimental manipulation. A previous study examining the role of Gq mediated
stimulation in LC cells may help to address this unexpected result. Thyrotropin-releasing
factor (TRF) is a neuropeptide that can modulate activity of LC cells in a phospholipase89

C (PLC) dependent manner. Administration of TRF in slices results in elevated discharge
from LC cells, but also decreases resting membrane K+ conductance, which facilitated
burst activity following periods of inhibition (Ishibashi et al., 2009). Phasic activity in LC
neurons is characterized by an overall suppression of baseline activity and task-related
phasic bursts that are thought to facilitate a directed behavioral response. Therefore, it
may be possible that CNO stimulation of Gq signaling pathways facilitates tonic and
phasic activity and that switches between these modes of activity remain dependent on
task contingencies. In this condition, it is uncertain that CNO administered in LC would
exogenously and independently induce a tonic pattern of neuronal activity. In other words,
CNO may only facilitate ongoing tonic or phasic activity in LC cells rather than
unidirectionally biasing LC into a tonic mode. However, when CNO is administered in
mPFC, tonic synaptic release of NA may be facilitated regardless of ongoing activity
within the LC nucleus, which results in improved performance on the aSST. Although,
this would still fail to explain the lack of effect on perseverative errors when CNO was
administered in mPFC. But, as previously explained, an effect on perseveration may be
difficult to attain within this particular behavioral framework by only manipulating LC
inputs.
These regionally specific results raise the question of whether the lack of effect
seen in the optogenetic experiments may have been due to similar circumstances. Recall,
that these experiments only delivered light stimulation to the LC nucleus itself and not to
efferent targets. It is possible then that exogenously stimulating LC optogenetically could
produce the same conflicting behavioral outcomes depending on which neurons received
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stimulation. A future experiment could reinforce these findings by placing light fibers in
mPFC and stimulating ChR2 expressing LC terminals following the rule change on the
EDS. If then no effect is seen, it may be reasonable to conclude that the lack of effects in
ChR2 experiments might be the result of technical concerns already addressed. However,
if the same regionally specific effect on TTC is witnessed, it would suggest that one or
more of these proposed mechanisms may be at play. If tethering of the animal continued
to be a concern, use of bistable opsins that can be persistently activated or inactivated
with single pulses of light (Berndt et al., 2009) could be incorporated. These opsins could
also potentially overcome concerns related to the induction of rhythmic activation of the
cells in response to light input.
Further experiments will also be required to determine the target through which
stimulated LC terminals are exerting the effect witnessed here. The most straightforward
approach would be to co-infuse antagonists with CNO into mPFC. If this effect is simply
due to facilitated release of NE, it should be blocked by co-infusion of the beta antagonist
propranolol, the alpha-1 antagonist prazosin, the alpha-2 antagonist atipamezole, or any
combination thereof. If none of these antagonists masked the improved performance,
non-NA sources of this effect, such as DA, glutamate, or galanin would also have to be
examined.
Although the mechanism responsible for these effects remains to be determined,
these experiments do provide direct evidence that inputs from LC to mPFC are sufficient
to improve set-shifting performance. However, these manipulations were not sufficient to
independently interrupt an ongoing pattern of behavior as would be predicted by adaptive
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gain theory. Adaptive gain theory posits that a pattern of tonic LC activity serves to
actively disengage a respondent from a current pattern of behavior when the value of
performing that behavior outweighs the cost. Perseveration then could be the result of LC
remaining in a phasic pattern of activity until the point that enough evidence can be
accumulated to update the declining value of continuing to perform that behavior. In
these experiments, we attempted to force LC into a tonic mode independently of this
lagging calculation. This claim comes with the caveat that an actual tonic stimulation was
achieved from our manipulations, which as was previously addressed, remains to be
confirmed. But, presuming this was the case, it is quite evident that our manipulations
failed to induce a distractible or disengaged state. Two of the variables measured in the
DREADD experiments speak directly to this question. First, following CNO
microinjection, animals were still willing and able to accurately recall and perform the
known behavior prior to the rule change. This was the case regardless of where the CNO
microinjection was delivered. Second, these manipulations were not able to reduce
perseverative behavior. This may indicate that LC alone is not able to force a distractible
state independently of the ongoing calculation of behavioral utility. This would imply
that LC is not solely responsible for initiating this transition. This is perhaps not
surprising given the role of other systems such as VTA dopamine in mediating reward
based motivated behavior. Further experiments may be able to verify that these
manipulations are producing a physiologically relevant tonic mode of activity. However,
if these hypothetical experiments still fail to capture a reduction of perseverative
responding, any resulting explanation of the substrates of behavioral flexibility will not
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be able proceed without fully integrating the influence of other neural systems. The
necessary tools to conduct such a complex analyses are only now becoming available.
Ideally, full control over multiple independent cell types could be achieved to completely
dissect this behavior.
It may be the case that this task environment was not complex enough to witness
the flexible phenotype these experiments were sought to capture. At its heart, any given
trial was ultimately a 50/50 choice between the right or left lever. So, if the animal was
using no particular strategy to perform the task, it will likely still receive the reward on
50% of trials. Given additional options, a subtle modification of strategy may become
more obvious than what can be captured by this task. Future experiments to this end may
need to incorporate an array of possible responses, additional stimulus dimensions, or
variable reinforcement ratios in order to find an apt direct measure of flexibility beyond
simple improvement in task performance.
Alternatively, it could be the case that perseveration, as modulated by NE, is
mediated at a different site than PFC. Habitual type behaviors are commonly thought to
be mediated by recurrent circuitry between PFC and dorsal striatum (Reading et al.,
1991; Schmitzer-Torbert et al., 2014). However, in the rat, dorsal striatum does not
receive innervation from LC (Sara, 2009) making this an unlikely target for NE in
perseverative behavior. However, other studies have shown that tonic and phasic patterns
of LC stimulation can selective strengthen or attenuate thalamic responses to incoming
sensory stimuli(Berridge and Waterhouse, 2003; Devilbiss and Waterhouse, 2011). So, it
may be possible that induction of tonic NE activity in thalamus could act to weaken
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stimulus associations related to the old rule and mediate perseverative responding on this
task.
That is not to imply, however, that these data fail to support some tenets of
adaptive gain theory. By its simplest interpretation, the manipulations employed by this
set of experiments should be sufficient to improve performance on tasks measuring
flexible behavior. That is exactly what has been achieved. That it does so by reducing
regressive responding and strengthening the alternate behavioral response later in the
EDS session rather than reducing perseveration does not disqualify a role for LC in
producing a flexible behavioral phenotype. Rather, it could imply that the correct
interpretation is more complex than can be captured by these analyses. An alternative
explanation of how induction of tonic NE release in PFC could facilitate acquisition of
the new reward contingency is that tonic LC activity may only disengage certain aspects
of the behavior, such as arousal towards the task cues or overall attentiveness. Meanwhile,
other relevant networks, remaining free of experimental influence, can maintain the
ongoing behavior. However, once these systems relent to the new task demands, LC may
have already sensitized to the new task contingencies and can subserve a more rapid
utilization of the new behavior. However, these explanations are far beyond the scope of
the current experiment.
These results could indicate an unforeseen issue with the unprecedented
selectivity conveyed by these new experimental techniques, especially when they are
used in such complex behaviors. The effect sizes witnessed in these results are fairly
modest and the behaviors tested are quite complex. So, although we are able to control
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select population with these new manipulations, it may only influence a small aspect of
an otherwise very complex behavior. In other words, although our manipulations may
reduce variability due to their specificity, that specificity may make it more difficult to
witness drastic effects as a given behavior becomes more complex.
In its most straightforward interpretation, these data show that performance on a
strategy set-shifting task can be improved by administering cell-specific stimulation to
LC terminals in the mPFC. This improved performance results from a decrease in
regressive responding, which is associated with an increase in win/stay behavior in the
trials before the animal achieves a streak of 20 correct trials. So, stimulation of mPFC
NA terminals this task is improving the animals’ ability to consistently apply the new
behavior sooner in the EDS. Although the physiological mechanism behind this effect
remains to be determined, these results strengthen understanding of the role of LC in
mediating flexible behavior and managing trade-offs in light of dynamic environmental
contingencies.
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